<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:48:10Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3614978" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3614978</identifier><datestamp>2013-04-05</datestamp><setSpec>plosone</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3614978</article-id>
      <article-id pub-id-type="pmcid">PMC3614978</article-id>
      <article-id pub-id-type="pmc-uid">3614978</article-id>
      <article-id pub-id-type="pmid">23565137</article-id>
      <article-id pub-id-type="pmid">23565137</article-id>
      <article-id pub-id-type="publisher-id">PONE-D-12-34104</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0058618</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Human Genetics</subject>
              <subj-group>
                <subject>Genome-Wide Association Studies</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Molecular Genetics</subject>
              <subj-group>
                <subject>Gene Identification and Analysis</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Population Genetics</subject>
              <subj-group>
                <subject>Genetic Polymorphism</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Genetics of Disease</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Epidemiology</subject>
            <subj-group>
              <subject>Genetic Epidemiology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Neurology</subject>
            <subj-group>
              <subject>Dementia</subject>
              <subj-group>
                <subject>Alzheimer Disease</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>
<italic>SORL1</italic> Is Genetically Associated with Late-Onset Alzheimerâs Disease in Japanese, Koreans and Caucasians</article-title>
        <alt-title alt-title-type="running-head"><italic>SORL1</italic> Association with AD in Multiple Populations</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Miyashita</surname>
            <given-names>Akinori</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Koike</surname>
            <given-names>Asako</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Jun</surname>
            <given-names>Gyungah</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Li-San</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author" deceased="yes">
          <name>
            <surname>Takahashi</surname>
            <given-names>Satoshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matsubara</surname>
            <given-names>Etsuro</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kawarabayashi</surname>
            <given-names>Takeshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shoji</surname>
            <given-names>Mikio</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tomita</surname>
            <given-names>Naoki</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arai</surname>
            <given-names>Hiroyuki</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Asada</surname>
            <given-names>Takashi</given-names>
          </name>
          <xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harigaya</surname>
            <given-names>Yasuo</given-names>
          </name>
          <xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ikeda</surname>
            <given-names>Masaki</given-names>
          </name>
          <xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Amari</surname>
            <given-names>Masakuni</given-names>
          </name>
          <xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hanyu</surname>
            <given-names>Haruo</given-names>
          </name>
          <xref ref-type="aff" rid="aff11">
<sup>11</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Higuchi</surname>
            <given-names>Susumu</given-names>
          </name>
          <xref ref-type="aff" rid="aff12">
<sup>12</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ikeuchi</surname>
            <given-names>Takeshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff13">
<sup>13</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nishizawa</surname>
            <given-names>Masatoyo</given-names>
          </name>
          <xref ref-type="aff" rid="aff13">
<sup>13</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suga</surname>
            <given-names>Masaichi</given-names>
          </name>
          <xref ref-type="aff" rid="aff14">
<sup>14</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kawase</surname>
            <given-names>Yasuhiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff15">
<sup>15</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Akatsu</surname>
            <given-names>Hiroyasu</given-names>
          </name>
          <xref ref-type="aff" rid="aff16">
<sup>16</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kosaka</surname>
            <given-names>Kenji</given-names>
          </name>
          <xref ref-type="aff" rid="aff16">
<sup>16</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yamamoto</surname>
            <given-names>Takayuki</given-names>
          </name>
          <xref ref-type="aff" rid="aff16">
<sup>16</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Imagawa</surname>
            <given-names>Masaki</given-names>
          </name>
          <xref ref-type="aff" rid="aff17">
<sup>17</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hamaguchi</surname>
            <given-names>Tsuyoshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff18">
<sup>18</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yamada</surname>
            <given-names>Masahito</given-names>
          </name>
          <xref ref-type="aff" rid="aff18">
<sup>18</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moriaha</surname>
            <given-names>Takashi</given-names>
          </name>
          <xref ref-type="aff" rid="aff19">
<sup>19</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takeda</surname>
            <given-names>Masatoshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff19">
<sup>19</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takao</surname>
            <given-names>Takeo</given-names>
          </name>
          <xref ref-type="aff" rid="aff20">
<sup>20</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nakata</surname>
            <given-names>Kenji</given-names>
          </name>
          <xref ref-type="aff" rid="aff21">
<sup>21</sup>
</xref>
        </contrib>
        <contrib contrib-type="author" deceased="yes">
          <name>
            <surname>Fujisawa</surname>
            <given-names>Yoshikatsu</given-names>
          </name>
          <xref ref-type="aff" rid="aff21">
<sup>21</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sasaki</surname>
            <given-names>Ken</given-names>
          </name>
          <xref ref-type="aff" rid="aff21">
<sup>21</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watanabe</surname>
            <given-names>Ken</given-names>
          </name>
          <xref ref-type="aff" rid="aff22">
<sup>22</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nakashima</surname>
            <given-names>Kenji</given-names>
          </name>
          <xref ref-type="aff" rid="aff23">
<sup>23</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Urakami</surname>
            <given-names>Katsuya</given-names>
          </name>
          <xref ref-type="aff" rid="aff24">
<sup>24</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ooya</surname>
            <given-names>Terumi</given-names>
          </name>
          <xref ref-type="aff" rid="aff25">
<sup>25</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takahashi</surname>
            <given-names>Mitsuo</given-names>
          </name>
          <xref ref-type="aff" rid="aff26">
<sup>26</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yuzuriha</surname>
            <given-names>Takefumi</given-names>
          </name>
          <xref ref-type="aff" rid="aff27">
<sup>27</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Serikawa</surname>
            <given-names>Kayoko</given-names>
          </name>
          <xref ref-type="aff" rid="aff28">
<sup>28</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoshimoto</surname>
            <given-names>Seishi</given-names>
          </name>
          <xref ref-type="aff" rid="aff28">
<sup>28</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nakagawa</surname>
            <given-names>Ryuji</given-names>
          </name>
          <xref ref-type="aff" rid="aff28">
<sup>28</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Jong-Won</given-names>
          </name>
          <xref ref-type="aff" rid="aff29">
<sup>29</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ki</surname>
            <given-names>Chang-Seok</given-names>
          </name>
          <xref ref-type="aff" rid="aff29">
<sup>29</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Won</surname>
            <given-names>Hong-Hee</given-names>
          </name>
          <xref ref-type="aff" rid="aff29">
<sup>29</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Na</surname>
            <given-names>Duk L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff30">
<sup>30</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Seo</surname>
            <given-names>Sang Won</given-names>
          </name>
          <xref ref-type="aff" rid="aff30">
<sup>30</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mook-Jung</surname>
            <given-names>Inhee</given-names>
          </name>
          <xref ref-type="aff" rid="aff31">
<sup>31</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <collab>The Alzheimer Disease Genetics Consortium</collab>
          <xref ref-type="author-notes" rid="fn3">
<sup>â¡</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>St. George-Hyslop</surname>
            <given-names>Peter</given-names>
          </name>
          <xref ref-type="aff" rid="aff32">
<sup>32</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mayeux</surname>
            <given-names>Richard</given-names>
          </name>
          <xref ref-type="aff" rid="aff33">
<sup>33</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haines</surname>
            <given-names>Jonathan L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff34">
<sup>34</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pericak-Vance</surname>
            <given-names>Margaret A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff35">
<sup>35</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoshida</surname>
            <given-names>Makiko</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nishida</surname>
            <given-names>Nao</given-names>
          </name>
          <xref ref-type="aff" rid="aff36">
<sup>36</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tokunaga</surname>
            <given-names>Katsushi</given-names>
          </name>
          <xref ref-type="aff" rid="aff36">
<sup>36</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yamamoto</surname>
            <given-names>Ken</given-names>
          </name>
          <xref ref-type="aff" rid="aff37">
<sup>37</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsuji</surname>
            <given-names>Shoji</given-names>
          </name>
          <xref ref-type="aff" rid="aff38">
<sup>38</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kanazawa</surname>
            <given-names>Ichiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff39">
<sup>39</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ihara</surname>
            <given-names>Yasuo</given-names>
          </name>
          <xref ref-type="aff" rid="aff40">
<sup>40</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schellenberg</surname>
            <given-names>Gerard D.</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Farrer</surname>
            <given-names>Lindsay A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
          <xref ref-type="aff" rid="aff41">
<sup>41</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
          <xref ref-type="author-notes" rid="fn2">
<sup>Â¶</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuwano</surname>
            <given-names>Ryozo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
          <xref ref-type="author-notes" rid="fn2">
<sup>Â¶</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
<label>1</label>
<addr-line>Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan</addr-line>
</aff>
      <aff id="aff2">
<label>2</label>
<addr-line>Central Research Laboratory, Hitachi Ltd, Tokyo, Japan</addr-line>
</aff>
      <aff id="aff3">
<label>3</label>
<addr-line>Departments of Medicine (Biomedical Genetics), Ophthalmology and Biostatistics, Boston University Schools of Medicine and Public Health, Boston, Massachusetts, United States of America</addr-line>
</aff>
      <aff id="aff4">
<label>4</label>
<addr-line>Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America</addr-line>
</aff>
      <aff id="aff5">
<label>5</label>
<addr-line>Department of Neurology, Iwate Medical University, Morioka, Japan</addr-line>
</aff>
      <aff id="aff6">
<label>6</label>
<addr-line>Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan</addr-line>
</aff>
      <aff id="aff7">
<label>7</label>
<addr-line>Department of Geriatric and Complementary Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan</addr-line>
</aff>
      <aff id="aff8">
<label>8</label>
<addr-line>Department of Psychiatry, University of Tsukuba, Tsukuba, Japan</addr-line>
</aff>
      <aff id="aff9">
<label>9</label>
<addr-line>Department of Neurology, Maebashi Red Cross Hospital, Maebashi, Japan</addr-line>
</aff>
      <aff id="aff10">
<label>10</label>
<addr-line>Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan</addr-line>
</aff>
      <aff id="aff11">
<label>11</label>
<addr-line>Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan</addr-line>
</aff>
      <aff id="aff12">
<label>12</label>
<addr-line>Division of Clinical Research, Kurihama Alcoholism Center, Yokosuka, Japan</addr-line>
</aff>
      <aff id="aff13">
<label>13</label>
<addr-line>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</addr-line>
</aff>
      <aff id="aff14">
<label>14</label>
<addr-line>Higashi Niigata Hospital, Niigata, Japan</addr-line>
</aff>
      <aff id="aff15">
<label>15</label>
<addr-line>Kawase Neurology Clinic, Sanjo, Japan</addr-line>
</aff>
      <aff id="aff16">
<label>16</label>
<addr-line>Choju Medical Institute, Fukushimura Hospital, Toyohashi, Japan</addr-line>
</aff>
      <aff id="aff17">
<label>17</label>
<addr-line>Imagawa Clinic, Osaka, Japan</addr-line>
</aff>
      <aff id="aff18">
<label>18</label>
<addr-line>Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan</addr-line>
</aff>
      <aff id="aff19">
<label>19</label>
<addr-line>Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka University, Osaka, Japan</addr-line>
</aff>
      <aff id="aff20">
<label>20</label>
<addr-line>Kurashiki Heisei Hospital, Kurashiki, Japan</addr-line>
</aff>
      <aff id="aff21">
<label>21</label>
<addr-line>Kinoko Espoir Hospital, Kasaoka, Japan</addr-line>
</aff>
      <aff id="aff22">
<label>22</label>
<addr-line>Watanabe Hospital, Tottori, Japan</addr-line>
</aff>
      <aff id="aff23">
<label>23</label>
<addr-line>Department of Neurology Tottori University, Yonago, Japan</addr-line>
</aff>
      <aff id="aff24">
<label>24</label>
<addr-line>Department of Biological Regulation, Section of Environment and Health Science, Tottori University, Yonago, Japan</addr-line>
</aff>
      <aff id="aff25">
<label>25</label>
<addr-line>Town Office, Onan, Japan</addr-line>
</aff>
      <aff id="aff26">
<label>26</label>
<addr-line>Department of Clinical Pharmacology, Fukuoka University, Fukuoka, Japan</addr-line>
</aff>
      <aff id="aff27">
<label>27</label>
<addr-line>Department of Psychiatry, National Hospital Organization, Hizen Psychiatric Center, Saga, Japan</addr-line>
</aff>
      <aff id="aff28">
<label>28</label>
<addr-line>Ureshino-Onsen Hospital, Saga, Japan</addr-line>
</aff>
      <aff id="aff29">
<label>29</label>
<addr-line>Department of Laboratory Medicine &amp; Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea</addr-line>
</aff>
      <aff id="aff30">
<label>30</label>
<addr-line>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea</addr-line>
</aff>
      <aff id="aff31">
<label>31</label>
<addr-line>Department of Biochemistry &amp; Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea</addr-line>
</aff>
      <aff id="aff32">
<label>32</label>
<addr-line>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada, and the Department of Clinical Neurosciences, Cambridge Institute for Medical Research, Cambridge, United Kingdom</addr-line>
</aff>
      <aff id="aff33">
<label>33</label>
<addr-line>Taub Institute on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University, New York, United States of America</addr-line>
</aff>
      <aff id="aff34">
<label>34</label>
<addr-line>Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America</addr-line>
</aff>
      <aff id="aff35">
<label>35</label>
<addr-line>The John P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States of America</addr-line>
</aff>
      <aff id="aff36">
<label>36</label>
<addr-line>Department of Human Genetics, University of Tokyo, Tokyo, Japan</addr-line>
</aff>
      <aff id="aff37">
<label>37</label>
<addr-line>Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan</addr-line>
</aff>
      <aff id="aff38">
<label>38</label>
<addr-line>Department of Neurology, University of Tokyo, Tokyo, Japan</addr-line>
</aff>
      <aff id="aff39">
<label>39</label>
<addr-line>National Center for Neurology and Psychiatry, Kodaira, Japan</addr-line>
</aff>
      <aff id="aff40">
<label>40</label>
<addr-line>Department of Neuropathology, Doshisha University, Kyoto, Japan</addr-line>
</aff>
      <aff id="aff41">
<label>41</label>
<addr-line>Departments of Neurology, Ophthalmology, Genetics &amp; Genomics, and Epidemiology, Boston University Schools of Medicine and Public Health, Boston, Massachusetts, United States of America</addr-line>
</aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Toft</surname>
            <given-names>Mathias</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
<addr-line>Oslo University Hospital, Norway</addr-line>
</aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email>ryosun@bri.niigata-u.ac.jp</email> (RK); <email>farrer@bu.edu</email> (LAF)</corresp>
        <fn id="fn2" fn-type="other">
          <p>Â¶ These authors also contributed equally to this work.</p>
        </fn>
        <fn id="fn3" fn-type="other">
          <p>â¡ Membership of The Alzheimer Disease Genetics Consortium is provided in the Acknowledgments.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Competing Interests: </bold>We have the following interests. The Kathleen Price Bryan Brain Bank at Duke University Medical Center is funded by NINDS grant #NS39764, NIMH MH60451 and by Glaxo Smith Kline. Genotyping of the TGEN2 cohort was supported by Kronos Science. Asako Koike and Makiko Yoshida are employed by Central Research Laboratory, Hitachi Ltd. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.</p>
        </fn>
        <fn fn-type="con">
          <p>Critical revision of the manuscript for important intellectual content: RM JH MP-V GS LAF RK. Obtained funding: J-WK RM JH MP-V GS LAF RK. Conceived and designed the experiments: JG KT ST J-WK LAF RK. Performed the experiments: AM NN KT KY RK. Analyzed the data: GJ AK L-SW MY AM LAF. Contributed reagents/materials/analysis tools: ST EM TK M. Shoji NT HA TA YH M. Ikeda MA HH SH TI MN TM M. Suga YK HA TY KK M. Imagawa TH MY TT KN YF K. Sasaki KW YW KU TO MT TY K. Serikawa SY RN DLN SWS C-SK H-HW IM-J The Alzheimer's Disease Genetics Consortium PSG-H RM JH MP-V GS LAF IK YI RK. Wrote the paper: GJ AM AK LAF RK.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>2</day>
        <month>4</month>
        <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <issue>4</issue>
      <elocation-id>e58618</elocation-id>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>2</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2013 Miyashita et al</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Miyashita et al</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>To discover susceptibility genes of late-onset Alzheimerâs disease (LOAD), we conducted a 3-stage genome-wide association study (GWAS) using three populations: Japanese from the Japanese Genetic Consortium for Alzheimer Disease (JGSCAD), Koreans, and Caucasians from the Alzheimer Disease Genetic Consortium (ADGC). In Stage 1, we evaluated data for 5,877,918 genotyped and imputed SNPs in Japanese cases (nâ=â1,008) and controls (nâ=â1,016). Genome-wide significance was observed with 12 SNPs in the <italic>APOE</italic> region. Seven SNPs from other distinct regions with p-values &lt;2Ã10<sup>â5</sup> were genotyped in a second Japanese sample (885 cases, 985 controls), and evidence of association was confirmed for one <italic>SORL1</italic> SNP (rs3781834, Pâ=â7.33Ã10<sup>â7</sup> in the combined sample). Subsequent analysis combining results for several SORL1 SNPs in the Japanese, Korean (339 cases, 1,129 controls) and Caucasians (11,840 AD cases, 10,931 controls) revealed genome wide significance with rs11218343 (Pâ=â1.77Ã10<sup>â9</sup>) and rs3781834 (Pâ=â1.04Ã10<sup>â8</sup>). SNPs in previously established AD loci in Caucasians showed strong evidence of association in Japanese including rs3851179 near <italic>PICALM</italic> (Pâ=â1.71Ã10<sup>â5</sup>) and rs744373 near <italic>BIN1</italic> (Pâ=â1.39Ã10<sup>â4</sup>). The associated allele for each of these SNPs was the same as in Caucasians. These data demonstrate for the first time genome-wide significance of LOAD with <italic>SORL1</italic> and confirm the role of other known loci for LOAD in Japanese. Our study highlights the importance of examining associations in multiple ethnic populations.</p>
      </abstract>
      <funding-group>
        <funding-statement>This study was supported by a Grants-in-Aid for Scientific Research on Priority Areas, âAdvanced Brain Science Projectâ (Y.I.), âComprehensive Genomicsâ (R.K., K.T. and K.Y.), and âApplied Genomicsâ (S.T.) and âIntegrated Database Projectâ (A.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, âJapanese Alzheimerâs Disease Neuroimaging Initiativeâ (R.K.) by New Energy and Industrial Technology Development Organization (NEDO) in Japan, and by a grant from the Korea Health Technology R&amp;D Project, Ministry of Health &amp; Welfare, Republic of Korea (A120030). The United States National Institutes of Health (NIH), National Institute on Aging (NIH-NIA) supported this work through the following grants: ADGC, U01 AG032984, RC2 AG036528; NACC, U01 AG016976; NCRAD, U24 AG021886; NIA LOAD, U24 AG026395, U24 AG026390; BU ADC P30; MIRAGE R01 AG025259; Banner Sun Health Research Institute P30 AG019610; Boston University, P30 AG013846, U01 AG10483, R01 CA129769, R01 MH080295, R01 AG017173, R01AG33193; Columbia University, P50 AG008702, R37 AG015473; Duke University, P30 AG028377, AG05128; Emory University, AG025688; Group Health Research Institute, UO1 AG06781, UO1 HG004610; Indiana University, P30 AG10133; Johns Hopkins University, P50 AG005146, R01 AG020688; Massachusetts General Hospital, P50 AG005134; Mayo Clinic, P50 AG016574; Mount Sinai School of Medicine, P50 AG005138, P01 AG002219; New York University, P30 AG08051, MO1RR00096, and UL1 RR029893; Northwestern University, P30 AG013854; Oregon Health &amp; Science University, P30 AG008017, R01 AG026916; Rush University, P30 AG010161, R01 AG019085, R01 AG15819, R01 AG17917, R01 AG30146; TGen, R01 NS059873; University of Alabama at Birmingham, P50 AG016582, UL1RR02777; University of Arizona, R01 AG031581; University of California, Davis, P30 AG010129; University of California, Irvine, P50 AG016573, P50, P50 AG016575, P50 AG016576, P50 AG016577; University of California, Los Angeles, P50 AG016570; University of California, San Diego, P50 AG005131; University of California, San Francisco, P50 AG023501, P01 AG019724; University of Kentucky, P30 AG028383; University of Michigan, P50 AG008671; University of Pennsylvania, P30 AG010124; University of Pittsburgh, P50 AG005133, AG030653; University of Southern California, P50 AG005142; University of Texas Southwestern, P30 AG012300; University of Miami, R01 AG027944, AG010491, AG027944, AG021547, AG019757; University of Washington, P50 AG005136; Vanderbilt University, R01 AG019085; and Washington University, P50 AG005681, P01 AG03991. The Kathleen Price Bryan Brain Bank at Duke University Medical Center is funded by NINDS grant #NS39764, NIMH MH60451 and by Glaxo Smith Kline. Genotyping of the TGEN2 cohort was supported by Kronos Science. The TGen series was also funded by NIA grant AG034504 to AJM, The Banner Alzheimerâs Foundation, The Johnnie B. Byrd Sr. Alzheimerâs Institute, the Medical Research Council, and the state of Arizona and also includes samples from the following sites: Newcastle Brain Tissue Resource (funding via the Medical Research Council, local NHS trusts and Newcastle University), MRC London Brain Bank for Neurodegenerative Diseases (funding via the Medical Research Council), South West Dementia Brain Bank (funding via numerous sources including the Higher Education Funding Council for England (HEFCE), Alzheimerâs Research Trust (ART), BRACE as well as North Bristol NHS Trust Research and Innovation Department and DeNDRoN), The Netherlands Brain Bank (funding via numerous sources including Stichting MS Research, Brain Net Europe, Hersenstichting Nederland Breinbrekend Werk, International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek), Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona. Marcelle Morrison-Bogorad, PhD, Tony Phelps, PhD, and Walter Kukull, PhD, are thanked for helping to co-ordinate this collection. ADNI Funding for ADNI is through the Northern California Institute for Research and Education by grants from Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., Alzheimer's Association, Alzheimer's Drug Discovery Foundation, the Dana Foundation, and by the National Institute of Biomedical Imaging and Bioengineering and NIA grants U01 AG024904, RC2 AG036535, K01 AG030514. The authors thank Drs. D. Stephen Snyder and Marilyn Miller from NIA who are ex-officio ADGC members. Support was also from the Alzheimerâs Association (LAF, IIRG-08-89720; MP-V, IIRG-05-14147) and the US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program. P.S.G.-H. is supported by the Wellcome Trust, Howard Hughes Medical Institute, and Canadian Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
      <counts>
        <page-count count="11"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Alzheimerâs disease (AD) is a progressive neurodegenerative disorder characterized by cognitive dysfunction and memory loss. Multiple rare mutations in <italic>APP</italic>, <italic>PSEN1</italic>, <italic>PSEN2</italic> and <italic>SORL1</italic> account for most cases of early-onset autosomal dominant AD <xref rid="pone.0058618-ErtekinTaner1" ref-type="bibr">[1]</xref>, <xref rid="pone.0058618-Pottier1" ref-type="bibr">[2]</xref>. Risk of late-onset AD (LOAD), the most common type of dementia in the elderly, is associated with complex interactions between genetic and environmental factors. Until recently, <italic>APOE</italic> was the only unequivocally recognized major susceptibility gene for LOAD <xref rid="pone.0058618-ErtekinTaner1" ref-type="bibr">[1]</xref>, <xref rid="pone.0058618-Farrer1" ref-type="bibr">[3]</xref>. Several genome-wide association studies (GWAS) each including more than 5,000 Caucasians identified genome-wide significant associations for LOAD with nine other loci including <italic>ABCA7</italic>, <italic>BIN1</italic>, <italic>CD2AP</italic>, <italic>CD33</italic>, <italic>CLU</italic>, <italic>CR1, EPHA1</italic>, <italic>MS4A</italic> gene cluster, and <italic>PICALM</italic>
<xref rid="pone.0058618-Hollingworth1" ref-type="bibr">[4]</xref>, <xref rid="pone.0058618-Naj1" ref-type="bibr">[5]</xref>. To our knowledge, no large GWAS for LOAD has been performed in any Asian population. Because there is a possibility that there exist ethnic-specific LOAD susceptibility variants, we carried out a large-scale GWAS to confirm associations at known loci and identify novel loci for LOAD using a three-stage design including a discovery Japanese cohort and replication cohorts of Japanese, Korean and Caucasian subjects.</p>
    </sec>
    <sec sec-type="methods" id="s2">
      <title>Methods</title>
      <sec id="s2a">
        <title>Subjects</title>
        <sec id="s2a1">
          <title>Japanese datasets</title>
          <p>Clinically defined subjects were recruited by the Japanese Genetic Study Consortium of Alzheimerâs Disease (JGSCAD: principal investigator, Y.I.) <xref rid="pone.0058618-Kuwano1" ref-type="bibr">[6]</xref>, <xref rid="pone.0058618-Miyashita1" ref-type="bibr">[7]</xref>. Probable AD cases were ascertained on the basis of the criteria of the National Institute of Neurological and Communicative Disorders, and Stroke-Alzheimerâs Disease and Related Disorders (NINCDS/ADRDA) <xref rid="pone.0058618-McKhann1" ref-type="bibr">[8]</xref>. The Mini-Mental State Examination <xref rid="pone.0058618-Folstein1" ref-type="bibr">[9]</xref>, Clinical Dementia Rating <xref rid="pone.0058618-Morris1" ref-type="bibr">[10]</xref>, and/or Function Assessment Staging <xref rid="pone.0058618-Reisberg1" ref-type="bibr">[11]</xref> were primarily used for evaluation of cognitive impairment. Elders living in an unassisted manner in the local community with no signs of dementia were used as controls. DNA was extracted from peripheral blood leukocytes using standard protocols <xref rid="pone.0058618-Kuwano1" ref-type="bibr">[6]</xref>. For the purpose of this study, the Stage 1 genome-wide association study (GWAS) dataset included 2024 subjects (1008 AD cases and 1016 controls) and the Stage 2 dataset included 1870 subjects (885 AD cases and 985 controls).</p>
        </sec>
        <sec id="s2a2">
          <title>Korean dataset</title>
          <p>A total of 339 subjects with AD were recruited at the Samsung Medical Center in Seoul, Korea. All AD subjects fulfilled NINCDS-ADRDA criteria for probable AD <xref rid="pone.0058618-McKhann1" ref-type="bibr">[8]</xref>. These subjects underwent a clinical interview and neurological examination that were previously described <xref rid="pone.0058618-Seo1" ref-type="bibr">[12]</xref>. The absence of secondary causes of cognitive deficits was assessed by laboratory tests including complete blood count, blood chemistry, vitamin B12/folate, syphilis serology, and thyroid function tests. Conventional brain MRI scans (T1-weighted, T2-weighted, and FLAIR images) confirmed the absence of territorial cerebral infarctions, brain tumors, and other structural lesions. Healthy control subjects (nâ=â1,129) ages 55 to 85 years were recruited from routine health examination at the same location and showed no evidence of cognitive dysfunction.</p>
        </sec>
        <sec id="s2a3">
          <title>Alzheimer Disease Genetics Consortium dataset</title>
          <p>Summarized information from tests of genetic association of AD with SNPs located in the candidate gene regions was culled from a recent large GWAS conducted by the Alzheimer Disease Genetics Consortium (ADGC) <xref rid="pone.0058618-Naj1" ref-type="bibr">[5]</xref>. Results were computed for SNPs throughout the genome in a sample composed of 11,840 AD cases and 10,931 cognitively normal elders from 15 independent Caucasian data sets. Details of the quality control and statistical analysis procedures and genetic models has been published elsewhere <xref rid="pone.0058618-Naj1" ref-type="bibr">[5]</xref>.</p>
          <p>This study was approved by the Boston University Institutional Review Board, Institutional Review Board of Niigata University, and the Institutional Review Boards of all participating institutions. Written informed consent was obtained from all participants. Next of kin, carer takers or guardians consented on the behalf of participants whose capacity to consent was compromised. All subjects were anonymously genotyped. The basic demographics of the cases and controls before QC in each dataset are presented in <xref ref-type="table" rid="pone-0058618-t001">Table 1</xref>.</p>
          <table-wrap id="pone-0058618-t001" orientation="portrait" position="float">
            <object-id pub-id-type="doi">10.1371/journal.pone.0058618.t001</object-id>
            <label>Table 1</label>
            <caption>
              <title>Sample size and characteristics of the discovery and replication datasets.</title>
            </caption>
            <alternatives>
              <graphic id="pone-0058618-t001-1" xlink:href="pone.0058618.t001"/>
              <table frame="hsides" rules="groups">
                <colgroup span="1">
                  <col align="left" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Population (Stage)</td>
                    <td align="left" rowspan="1" colspan="1">Total</td>
                    <td colspan="5" align="left" rowspan="1">Alzheimer Disease Cases</td>
                    <td colspan="4" align="left" rowspan="1">Cognitively Normal Controls</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">N</td>
                    <td align="left" rowspan="1" colspan="1">Female (%)</td>
                    <td align="left" rowspan="1" colspan="1">Age at onset (mean Â± SD)</td>
                    <td align="left" rowspan="1" colspan="1">Age at exam (mean Â± SD)</td>
                    <td align="left" rowspan="1" colspan="1">
<italic>APOE</italic> Îµ2/Îµ3/Îµ4 Frequency</td>
                    <td align="left" rowspan="1" colspan="1">N</td>
                    <td align="left" rowspan="1" colspan="1">Female (%)</td>
                    <td align="left" rowspan="1" colspan="1">Age at exam (mean Â± SD)</td>
                    <td align="left" rowspan="1" colspan="1">
<italic>APOE</italic> Îµ2/Îµ3/Îµ4 Frequency</td>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Japanese Discovery (Stage 1)</td>
                    <td align="left" rowspan="1" colspan="1">2,024</td>
                    <td align="left" rowspan="1" colspan="1">1,008</td>
                    <td align="left" rowspan="1" colspan="1">723 (72%)</td>
                    <td align="left" rowspan="1" colspan="1">73.0 (4.28)</td>
                    <td align="left" rowspan="1" colspan="1">NA</td>
                    <td align="left" rowspan="1" colspan="1">0.02/0.65/0.33</td>
                    <td align="left" rowspan="1" colspan="1">1,016</td>
                    <td align="left" rowspan="1" colspan="1">583 (57%)</td>
                    <td align="left" rowspan="1" colspan="1">77.0 (5.89)</td>
                    <td align="left" rowspan="1" colspan="1">0.04/0.87/0.09</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Japanese Replication (Stage 2)</td>
                    <td align="left" rowspan="1" colspan="1">1,870</td>
                    <td align="left" rowspan="1" colspan="1">885</td>
                    <td align="left" rowspan="1" colspan="1">574 (65%)</td>
                    <td align="left" rowspan="1" colspan="1">74.3 (6.98)</td>
                    <td align="left" rowspan="1" colspan="1">NA</td>
                    <td align="left" rowspan="1" colspan="1">0.02/0.69/0.29</td>
                    <td align="left" rowspan="1" colspan="1">985</td>
                    <td align="left" rowspan="1" colspan="1">618 (63%)</td>
                    <td align="left" rowspan="1" colspan="1">73.74 (5.84)</td>
                    <td align="left" rowspan="1" colspan="1">0.05/0.86/0.09</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Korean (Stage 3)</td>
                    <td align="left" rowspan="1" colspan="1">1,468</td>
                    <td align="left" rowspan="1" colspan="1">339</td>
                    <td align="left" rowspan="1" colspan="1">245 (72%)</td>
                    <td align="left" rowspan="1" colspan="1">NA</td>
                    <td align="left" rowspan="1" colspan="1">73.67 (9.49)</td>
                    <td align="left" rowspan="1" colspan="1">0.03/0.70/0.27</td>
                    <td align="left" rowspan="1" colspan="1">1,129</td>
                    <td align="left" rowspan="1" colspan="1">550 (49%)</td>
                    <td align="left" rowspan="1" colspan="1">71.04 (4.86)</td>
                    <td align="left" rowspan="1" colspan="1">0.06/0.85/0.09</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Caucasian (Stage 3)</td>
                    <td align="left" rowspan="1" colspan="1">22,771</td>
                    <td align="left" rowspan="1" colspan="1">11,840</td>
                    <td align="left" rowspan="1" colspan="1">7168 (61%)</td>
                    <td align="left" rowspan="1" colspan="1">76.37 (5.18)</td>
                    <td align="left" rowspan="1" colspan="1">80.59 (4.92)</td>
                    <td align="left" rowspan="1" colspan="1">0.04/0.61/0.36</td>
                    <td align="left" rowspan="1" colspan="1">10,931</td>
                    <td align="left" rowspan="1" colspan="1">6418 (59%)</td>
                    <td align="left" rowspan="1" colspan="1">76.77 (3.55)</td>
                    <td align="left" rowspan="1" colspan="1">0.08/0.78/0.14</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">
<bold>TOTAL</bold>
</td>
                    <td align="left" rowspan="1" colspan="1">
<bold>28,133</bold>
</td>
                    <td align="left" rowspan="1" colspan="1">
<bold>14,072</bold>
</td>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">
<bold>14,061</bold>
</td>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                </tbody>
              </table>
            </alternatives>
          </table-wrap>
        </sec>
      </sec>
      <sec id="s2b">
        <title>Genotyping</title>
        <p>GWAS genotyping was performed in the Stage 1 sample using Affymetrix GeneChip 6.0 microarrays containing 909,622 SNPs. Applied Biosystemsâ (ABI) TaqMan Assays were used to genotype individual SNPs in the Japanese and Korean replication cohorts. <italic>APOE</italic> genotypes in the Japanese and Korean samples were determined by haplotypes derived from rs7412 and rs429358 which were genotyped using TaqMan Assays. Details of <italic>APOE</italic> genotyping in each ADGC dataset were described previously <xref rid="pone.0058618-Jun1" ref-type="bibr">[13]</xref>.</p>
      </sec>
      <sec id="s2c">
        <title>Quality Control and Population Substructure</title>
        <p>In the Stage 1 sample, SNPs with a genotype call rate (GCR) &lt;95%, a minor allele frequency (MAF) &lt;0.05, or significant deviation from the Hardy-Weinberg equilibrium (HWE) in controls (<italic>P</italic>&lt;10<sup>â6</sup>) were excluded. After excluding 83,673 low quality and 298,304 low frequency SNPs, we removed 196 subjects with a GCR &lt;95% and 41 subjects whose gender as determined by analysis of X-chromosome data using the PLINK program (ver. 1.06) <xref rid="pone.0058618-Purcell1" ref-type="bibr">[14]</xref> was inconsistent with the reported gender. The same QC procedures were applied to the Japanese and Korean replication datasets. We examined population substructure in the GWAS dataset by analyzing tagging SNPs from the genome-wide panels using the <italic>smartpca</italic> module from EIGENSTRAT software <xref rid="pone.0058618-Price1" ref-type="bibr">[15]</xref> in a manner described previously <xref rid="pone.0058618-Naj1" ref-type="bibr">[5]</xref>. Subsequently, we excluded three subjects who were cryptically related to other subjects in the dataset and 49 individuals who were population outliers. The strength of association of the top 10 principal components (PCs) was tested with AD status. The first three PCs were nominally associated with AD status. A total of 574,828 SNPs and 1,735 subjects comprising 891 cases and 844 controls passed the QC and were used for imputation and in further statistical analyses.</p>
      </sec>
      <sec id="s2d">
        <title>Genotype Imputation</title>
        <p>Genotypes for all SNPs in Japanese and Caucasians were imputed with the Markov Chain haplotyping (MaCH) software <xref rid="pone.0058618-Li1" ref-type="bibr">[16]</xref> using reference haplotypes in the 1000 Genomes database (version released in February 2012 for Japanese datasets and version released in December 2010 for Caucasian datasets). This procedure also filled in missing data for the genotyped SNPs. Imputation quality was determined as <italic>R<sup>2</sup></italic>, which estimates the squared correlation between imputed and true genotypes. We applied threshold criteria for quality control assessment of imputed SNPs (<italic>R<sup>2</sup></italic> â¥0.8) as recommended for 1000 Genomes imputed data using the IMPUTE2 program <xref rid="pone.0058618-Donnelly1" ref-type="bibr">[17]</xref>. Genotype probabilities for 5,877,918 genotyped and reliably imputed SNPs with a minor allele frequency (MAF) &gt;0.02 were included in the Japanese GWAS.</p>
      </sec>
      <sec id="s2e">
        <title>Statistical analysis</title>
        <p>Genotyped and imputed SNPs were tested for association with AD in the Stage 1 dataset using a logistic generalized linear model (GLM) controlling for age-at-onset (cases)/age-at-exam (controls), sex and the first three principal components from analysis of of population substructure. Stage 1 analyses were also performed based on a model adjusting for these covariates and the number of <italic>APOE</italic> Îµ4 alleles. SNPs in the <italic>APOE</italic> region (between map positions 45,000 kb and 45,800 kb on chromosome 19) were also tested for association in Îµ3/Îµ3 and Îµ3/Îµ4 subgroups. Genotyped SNPs were coded as 0, 1, or 2 according to the number of minor alleles under the additive genetic model. For imputed SNPs, a quantitative estimate between 0 and 2 for the dose of the minor allele were used to incorporate the uncertainty of the imputation estimates. All analyses were performed using PLINK. SNPs attaining a <italic>P</italic> value below 5Ã10<sup>â5</sup> were considered for replication in Stage 2. Initially, only one SNP per region was tested in the replication sample to minimize the penalty for multiple testing. Additional SNPs from regions meeting the signifcance threshold in the replication sample were also evaluated. SNPs with a <italic>P</italic> value below 1Ã10<sup>â5</sup> in the combined Stages 1 and 2 samples and nominally significant in Stage 2 (<italic>P</italic>&lt;0.05) were advanced to Stage 3.</p>
        <p>SNP association results obtained from individual datasets were combined by meta-analysis using the inverse variance method implemented in the software package METAL (<ext-link ext-link-type="uri" xlink:href="http://www.sph.umich.edu/csg/abecasis/Metal/index.html">http://www.sph.umich.edu/csg/abecasis/Metal/index.html</ext-link>) <xref rid="pone.0058618-Willer1" ref-type="bibr">[18]</xref>. An additive model was assumed and the association results across datasets were combined by summing the regression coefficients weighted by the inverse variance of the coefficients. The meta-analysis <italic>P-</italic>value of the association was estimated by the summarized test statistic, after applying a genomic control within each individual study. Effect sizes were weighted by their inverse variance and a combined estimate was calculated by summing the weighted estimates and dividing by the summed weights.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <p>The quantile-quantile plot indicated limited genomic inflation (Î»â=â1.04in the Stage 1 GWAS results (<xref ref-type="supplementary-material" rid="pone.0058618.s001">Fig. S1</xref>). A total of 125 SNPs from seven distinct regions showed evidence of association with <italic>P</italic>&lt;10<sup>â4</sup> (<xref ref-type="supplementary-material" rid="pone.0058618.s006">Table S1</xref>, <xref ref-type="supplementary-material" rid="pone.0058618.s002">Fig. S2</xref>). In addition to <italic>APOE</italic> SNP rs429358 (<italic>P</italic>â=â2.46Ã10<sup>â49</sup>, OR [95% CI] â=â5.5 [4.4â6.9]), 12 other SNPs in the <italic>APOE</italic> region were associated with LOAD at the genome-wide significance level of <italic>P</italic>&lt;5.0Ã10<sup>â8</sup>. The two most significant results in this group of SNPs were rs12610605 (<italic>PVRL2</italic>: <italic>P</italic>â=â1.38Ã10<sup>â13</sup>, OR [95% CI] â=â1.8 [1.5â2.0]) and rs62117161 (between <italic>CEACAM16</italic> and <italic>BCL3</italic>: <italic>P</italic>â=â3.46Ã10<sup>â12</sup>, OR [95% CI] â=â0.47 [0.38â0.58]). Since imputation in the <italic>APOE</italic> region using the 1000 Genomes reference panel is unreliable <xref rid="pone.0058618-Kuwano1" ref-type="bibr">[6]</xref>, we genotyped nine SNPs from this region, spanning multiple linkage disequilibrium (LD) blocks (<xref ref-type="supplementary-material" rid="pone.0058618.s003">Fig. S3</xref>) and that were nominally significant in the <italic>APOE</italic> Îµ3/Îµ3 subgroup, in the Japanese discovery and replication samples using TaqMan assays (<xref ref-type="supplementary-material" rid="pone.0058618.s007">Table S2</xref>). Genome-wide significant results were obtained for five of these SNPs, but only the association with <italic>PPP1R37</italic> SNP rs 17643262 remained nominally significant after adjustment for the number of <italic>APOE</italic> Îµ4 alleles (<italic>P</italic>â=â3.96Ã10<sup>â4</sup>) or in analyses stratified by <italic>APOE</italic> genotype (Îµ3/Îµ3: <italic>P</italic>â=â0.01; Îµ3/Îµ4: Pâ=â0.0016).</p>
      <p>SNPs from six other distinct chromosomal regions met Stage 2 follow-up criteria (<italic>P</italic>&lt;5Ã10<sup>â5</sup>) and the top SNP from each region was genotyped in an independent Japanese sample (<xref ref-type="table" rid="pone-0058618-t002">Table 2</xref>). Two SNPs were nominally significant in the replication sample, however the effect direction for <italic>KIAA0494</italic> SNP rs7519866 differed from the discovery sample. Modest evidence for replication was observed only with <italic>SORL1</italic> SNP rs4598682 (<italic>P</italic>â¤0.05). Subsequently, we selected an additional four <italic>SORL1</italic> SNPs (rs3781834, rs2282647, rs17125523, and rs3737529) for testing in the Japanese replication sample that were among the most significant in the basic or extended models in the discovery sample (<xref ref-type="supplementary-material" rid="pone.0058618.s006">Table S1</xref>) and not in LD with rs4598682 (r<sup>2</sup>&lt;0.2, <xref ref-type="supplementary-material" rid="pone.0058618.s004">Figure S4</xref>). Two of these SNPs (rs3781834 and rs17125523) were chosen also because they were genotyped in the discovery sample and thus would minimize the effects of potential imputation artifacts in meta-analysis of the two Japanese samples. Highly significant results were obtained for <italic>SORL1</italic> SNPs rs4598682 (<italic>P</italic>â=â9.51Ã10<sup>â6</sup>), rs3781834 (<italic>P</italic>â=â7.33Ã10<sup>â7</sup>), rs17125523 (<italic>P</italic>â=â5.51Ã10<sup>â6</sup>), and rs3737529 (<italic>P</italic>â=â4.14Ã10<sup>â6</sup>) after combining results from the discovery and replication samples (<xref ref-type="supplementary-material" rid="pone.0058618.s008">Table S3</xref>).</p>
      <table-wrap id="pone-0058618-t002" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0058618.t002</object-id>
        <label>Table 2</label>
        <caption>
          <title>Top-ranked genome-wide association results in the Japanese discovery (Stage 1) sample (P&lt;2.5Ã10<sup>â5</sup>) and their replication in Japanese (Stage 2).</title>
        </caption>
        <alternatives>
          <graphic id="pone-0058618-t002-2" xlink:href="pone.0058618.t002"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" rowspan="1" colspan="1">SNP</td>
                <td align="left" rowspan="1" colspan="1">CH:MB</td>
                <td align="left" rowspan="1" colspan="1">Nearest Gene</td>
                <td align="left" rowspan="1" colspan="1">MA</td>
                <td align="left" rowspan="1" colspan="1">MAF</td>
                <td align="left" rowspan="1" colspan="1"># SNPs</td>
                <td colspan="2" align="left" rowspan="1">Discovery (Stage 1)</td>
                <td colspan="2" align="left" rowspan="1">Replication (Stage 2)</td>
                <td colspan="2" align="left" rowspan="1">Meta-Analysis (Stages 1+2)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">P</td>
                <td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">P</td>
                <td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">P</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs7519866</td>
                <td align="left" rowspan="1" colspan="1">1:47.0</td>
                <td align="left" rowspan="1" colspan="1">
<italic>KIAA0494</italic>
</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.37</td>
                <td align="left" rowspan="1" colspan="1">52</td>
                <td align="left" rowspan="1" colspan="1">0.71 (0.61â0.83)</td>
                <td align="left" rowspan="1" colspan="1">9.70Ã10<sup>â6</sup>
</td>
                <td align="left" rowspan="1" colspan="1">1.15 (1.01â1.32)</td>
                <td align="left" rowspan="1" colspan="1">0.04</td>
                <td align="left" rowspan="1" colspan="1">0.90 (0.57â1.44)</td>
                <td align="left" rowspan="1" colspan="1">0.67</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs913360</td>
                <td align="left" rowspan="1" colspan="1">9:111.7</td>
                <td align="left" rowspan="1" colspan="1">
<italic>PALM2</italic>
</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.28</td>
                <td align="left" rowspan="1" colspan="1">20</td>
                <td align="left" rowspan="1" colspan="1">1.56 (1.43â1.70)</td>
                <td align="left" rowspan="1" colspan="1">1.83Ã10<sup>â7</sup>
</td>
                <td align="left" rowspan="1" colspan="1">1.11 (0.96â1.29)</td>
                <td align="left" rowspan="1" colspan="1">0.16</td>
                <td align="left" rowspan="1" colspan="1">1.29 (1.15â1.44)</td>
                <td align="left" rowspan="1" colspan="1">6.6Ã10<sup>â6</sup>
</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs1273007</td>
                <td align="left" rowspan="1" colspan="1">10:9.0</td>
                <td align="left" rowspan="1" colspan="1">
<italic>LOC338591</italic>
</td>
                <td align="left" rowspan="1" colspan="1">T</td>
                <td align="left" rowspan="1" colspan="1">0.27</td>
                <td align="left" rowspan="1" colspan="1">39</td>
                <td align="left" rowspan="1" colspan="1">0.68 (0.62â0.74)</td>
                <td align="left" rowspan="1" colspan="1">3.08Ã10<sup>â6</sup>
</td>
                <td align="left" rowspan="1" colspan="1">0.95 (0.81â1.10)</td>
                <td align="left" rowspan="1" colspan="1">0.47</td>
                <td align="left" rowspan="1" colspan="1">0.81 (0.73â0.91)</td>
                <td align="left" rowspan="1" colspan="1">2.2Ã10<sup>â4</sup>
</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs10898417</td>
                <td align="left" rowspan="1" colspan="1">11:85.2</td>
                <td align="left" rowspan="1" colspan="1">
<italic>SYTL2</italic>
</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.15</td>
                <td align="left" rowspan="1" colspan="1">2</td>
                <td align="left" rowspan="1" colspan="1">0.59 (0.53â0.66)</td>
                <td align="left" rowspan="1" colspan="1">1.17Ã10<sup>â6</sup>
</td>
                <td align="left" rowspan="1" colspan="1">1.02 (0.85â1.22)</td>
                <td align="left" rowspan="1" colspan="1">0.83</td>
                <td align="left" rowspan="1" colspan="1">0.82 (0.71â0.93)</td>
                <td align="left" rowspan="1" colspan="1">0.003</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs4598682</td>
                <td align="left" rowspan="1" colspan="1">11:121.1</td>
                <td align="left" rowspan="1" colspan="1">
<italic>SORL1</italic>
</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.23</td>
                <td align="left" rowspan="1" colspan="1">11</td>
                <td align="left" rowspan="1" colspan="1">0.68 (0.57â0.81)</td>
                <td align="left" rowspan="1" colspan="1">2.25Ã10<sup>â5</sup>
</td>
                <td align="left" rowspan="1" colspan="1">0.83 (0.68â1.00)</td>
                <td align="left" rowspan="1" colspan="1">0.05</td>
                <td align="left" rowspan="1" colspan="1">0.75 (0.66â0.85)</td>
                <td align="left" rowspan="1" colspan="1">9.5Ã10<sup>â6</sup>
</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs11621843</td>
                <td align="left" rowspan="1" colspan="1">14:92.2</td>
                <td align="left" rowspan="1" colspan="1">
<italic>RIN3</italic>
</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.26</td>
                <td align="left" rowspan="1" colspan="1">19</td>
                <td align="left" rowspan="1" colspan="1">1.47 (1.35â1.60)</td>
                <td align="left" rowspan="1" colspan="1">5.19Ã10<sup>â6</sup>
</td>
                <td align="left" rowspan="1" colspan="1">1.03 (0.88â1.20)</td>
                <td align="left" rowspan="1" colspan="1">0.72</td>
                <td align="left" rowspan="1" colspan="1">1.21 (1.08â1.36)</td>
                <td align="left" rowspan="1" colspan="1">8.1Ã10<sup>â4</sup>
</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="nt101">
            <label/>
            <p>CH:MB, chromosome:position (in megabasepairs, build 19); MA, minor allele; MAF, minor allele frequency; # SNPs, the number of SNPs for which Pâ¤1Ã10<sup>â4</sup> in the discovery (Stage 1) sample; OR, odds ratio; <italic>P</italic> P-value;</p>
          </fn>
          <fn id="nt102">
            <label/>
            <p>Selected SNPs represent the strongest association within each locus.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>These four <italic>SORL1</italic> SNPs showing significant association in the combined samples from Stages 1 and 2 were considered for further replication in Stage 3. We added rs11218343 to this stage of the analysis because it was the most significant <italic>SORL1</italic> SNP in the large Caucasian dataset (<italic>P</italic>â=â1.0Ã10<sup>â7</sup>), a result which emerged after pooling the Caucasian discovery GWAS sample and unpublished data in the replication sample from our previously published GWAS <xref rid="pone.0058618-Naj1" ref-type="bibr">[5]</xref>. These five SNPs were subsequently evaluated in Stage 3 by meta analysis including the Stage 1 and 2 Japanese, Korean and ADGC Caucasian datasets. SNPs rs11218343 (<italic>P</italic>â=â2.20Ã10<sup>â9</sup>) and rs3781834 (<italic>P</italic>â=â9.90Ã10<sup>â9</sup>), attained genome-wide significance in the sample of datasets from all stages (<xref ref-type="table" rid="pone-0058618-t003">Table 3</xref>, <xref ref-type="fig" rid="pone-0058618-g001">Fig. 1</xref>). There was modest evidence of replication for rs17125523 (meta <italic>P</italic>â=â3.30Ã10<sup>â6</sup>) and rs 3737529 (meta <italic>P</italic>â=â5.10Ã10<sup>â6</sup>). Although the allele frequencies for the top SNPs were very different between the Asian (MAF &gt;0.2) and Caucasian (MAF &lt;0.05) samples (<xref ref-type="table" rid="pone-0058618-t003">Table 3</xref>), there was no evidence of heterogeneity in the magnitude of the odds ratios or effect direction among the population groups (<italic>P</italic>&gt;0.15, <xref ref-type="fig" rid="pone-0058618-g002">Fig. 2</xref>). There was no apparent association in the comparably smaller Korean dataset; however, the direction of the effect for each SNP was the same as in the Japanese and Caucasian datsets.</p>
      <fig id="pone-0058618-g001" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0058618.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Regional association plot for the <italic>SORL1</italic> region on chromosome 11 in the three-stage design.</title>
          <p>For each SNP, the chromosomal location is shown on the x-axis and the significance level for association with LOAD is indicated by a âlog<sub>10</sub>P value on the y-axis. P-values are expressed as âlog<sub>10</sub>(P) (y-axis) for every tested SNP ordered by chromosomal location (x-axis). Genomic position was determined using the NCBI database (Build 37.1). Computed estimates of linkage disequilibrium (LD; r<sup>2</sup>) between SNPs in this region with the top-ranked SNP (rs3781834) in the Japanese discovery (J1) dataset are shown as red circles for r<sup>2</sup>â¥0.8, orange circles for 0.5â¤r<sup>2</sup>&lt;0.8, light blue circles for 0.2â¤r<sup>2</sup>&lt;0.5, and dark blue circles for r<sup>2</sup>&lt;0.2 using hg19/1000 Genomes of Asian populations (ASN; release on November 2010) combined from Han Chinese (CHB) and Japanese (JPT). Meta-analysis <italic>P</italic>-values are shown as purple diamonds for the Japanese datasets (J1+J2) and all datasets (J1+J2+K+C) including Japanese, Korean (K), and Caucasians (C). Two genome-wide significant SNPs in the final stage (rs3781834 and rs11218343) are presented. The gene structure and reading frame are shown below the plot. Exons are denoted with vertical bars. The LD between rs3781834 and rs11218343 is 0.57 in the ASN reference population.</p>
        </caption>
        <graphic xlink:href="pone.0058618.g001"/>
      </fig>
      <fig id="pone-0058618-g002" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0058618.g002</object-id>
        <label>Figure 2</label>
        <caption>
          <title>Forest plots of the two most strongly associated SNPs, rs3781834 (A) and rs11218343 (B), in the <italic>SORL1</italic> region showing the strength and pattern of significance in the Japanese discovery and each replication dataset in the model of adjusting for population structure, age, and sex.</title>
        </caption>
        <graphic xlink:href="pone.0058618.g002"/>
      </fig>
      <table-wrap id="pone-0058618-t003" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0058618.t003</object-id>
        <label>Table 3</label>
        <caption>
          <title>Meta-analysis of top-ranked association results with <italic>SORL1</italic> in Japanese, Korean, and Caucasian datasets.</title>
        </caption>
        <alternatives>
          <graphic id="pone-0058618-t003-3" xlink:href="pone.0058618.t003"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" rowspan="1" colspan="1">SNP</td>
                <td align="left" rowspan="1" colspan="1">MA</td>
                <td colspan="3" align="left" rowspan="1">Japanese (Stage 1+2)</td>
                <td colspan="3" align="left" rowspan="1">Korean (Stage 3)</td>
                <td colspan="3" align="left" rowspan="1">Caucasian (Stage 3)</td>
                <td colspan="2" align="left" rowspan="1">Meta-Analysis (Stages 1â3)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">MAF</td>
                <td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">P</td>
                <td align="left" rowspan="1" colspan="1">MAF</td>
                <td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">P</td>
                <td align="left" rowspan="1" colspan="1">MAF</td>
                <td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">P</td>
                <td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">P</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs4598682</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.23</td>
                <td align="left" rowspan="1" colspan="1">0.75 (0.66â0.85)</td>
                <td align="left" rowspan="1" colspan="1">9.5Ã10<sup>â6</sup>
</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">not available</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">0.02</td>
                <td align="left" rowspan="1" colspan="1">1.04 (0.85â1.28)</td>
                <td align="left" rowspan="1" colspan="1">0.68</td>
                <td align="left" rowspan="1" colspan="1">0.82 (0.72â0.93)</td>
                <td align="left" rowspan="1" colspan="1">3.6Ã10<sup>â3</sup>
</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs11218343</td>
                <td align="left" rowspan="1" colspan="1">C</td>
                <td align="left" rowspan="1" colspan="1">0.34</td>
                <td align="left" rowspan="1" colspan="1">0.83 (0.75â0.92)</td>
                <td align="left" rowspan="1" colspan="1">3.8Ã10<sup>â4</sup>
</td>
                <td align="left" rowspan="1" colspan="1">0.31</td>
                <td align="left" rowspan="1" colspan="1">0.96 (0.79â1.17)</td>
                <td align="left" rowspan="1" colspan="1">0.68</td>
                <td align="left" rowspan="1" colspan="1">0.04</td>
                <td align="left" rowspan="1" colspan="1">0.75 (0.67â0.83)</td>
                <td align="left" rowspan="1" colspan="1">1.0Ã10<sup>â7</sup>
</td>
                <td align="left" rowspan="1" colspan="1">0.81 (0.75â0.87)</td>
                <td align="left" rowspan="1" colspan="1">2.2Ã10<sup>â9</sup>
</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs3781834</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.23</td>
                <td align="left" rowspan="1" colspan="1">0.74 (0.66â0.84)</td>
                <td align="left" rowspan="1" colspan="1">7.3Ã10<sup>â7</sup>
</td>
                <td align="left" rowspan="1" colspan="1">0.23</td>
                <td align="left" rowspan="1" colspan="1">0.94 (0.75â1.16)</td>
                <td align="left" rowspan="1" colspan="1">0.55</td>
                <td align="left" rowspan="1" colspan="1">0.02</td>
                <td align="left" rowspan="1" colspan="1">0.78 (0.68â0.9)</td>
                <td align="left" rowspan="1" colspan="1">7.9Ã10<sup>â4</sup>
</td>
                <td align="left" rowspan="1" colspan="1">0.78 (0.72â0.85)</td>
                <td align="left" rowspan="1" colspan="1">9.9Ã10<sup>â9</sup>
</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs17125523</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.25</td>
                <td align="left" rowspan="1" colspan="1">0.77 (0.68â0.86)</td>
                <td align="left" rowspan="1" colspan="1">5.5Ã10<sup>â6</sup>
</td>
                <td align="left" rowspan="1" colspan="1">0.23</td>
                <td align="left" rowspan="1" colspan="1">0.96 (0.78â1.19)</td>
                <td align="left" rowspan="1" colspan="1">0.72</td>
                <td align="left" rowspan="1" colspan="1">0.02</td>
                <td align="left" rowspan="1" colspan="1">0.85 (0.74â0.99)</td>
                <td align="left" rowspan="1" colspan="1">0.034</td>
                <td align="left" rowspan="1" colspan="1">0.82 (0.76â0.89)</td>
                <td align="left" rowspan="1" colspan="1">3.3Ã10<sup>â6</sup>
</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">rs3737529</td>
                <td align="left" rowspan="1" colspan="1">T</td>
                <td align="left" rowspan="1" colspan="1">0.25</td>
                <td align="left" rowspan="1" colspan="1">0.77 (0.68â0.86)</td>
                <td align="left" rowspan="1" colspan="1">4.1Ã10<sup>â6</sup>
</td>
                <td align="left" rowspan="1" colspan="1">0.26</td>
                <td align="left" rowspan="1" colspan="1">1.04 (0.84â1.29)</td>
                <td align="left" rowspan="1" colspan="1">0.70</td>
                <td align="left" rowspan="1" colspan="1">0.02</td>
                <td align="left" rowspan="1" colspan="1">0.83 (0.71â0.97)</td>
                <td align="left" rowspan="1" colspan="1">0.016</td>
                <td align="left" rowspan="1" colspan="1">0.82 (0.76â0.89)</td>
                <td align="left" rowspan="1" colspan="1">5.1Ã10<sup>â6</sup>
</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="nt103">
            <label/>
            <p>CH:MB, chromosome:position (in megabase pairs, build 19); MA, minor allele; MAF, minor allele frequenc; OR, odds ratio; <italic>P</italic> P-value.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Next, we investigated whether robust genetic associations for LOAD reported previously in Caucasians <xref rid="pone.0058618-Hollingworth1" ref-type="bibr">[4]</xref>, <xref rid="pone.0058618-Naj1" ref-type="bibr">[5]</xref> generalize to Japanese. After correcting for 15 tests, SNPs rs3851179 located approximately 90 kb upstream from <italic>PICALM</italic> (<italic>P</italic>â=â1.71Ã10<sup>â5</sup>) and rs744373 located approximately 30 kb upstream from <italic>BIN1</italic> (<italic>P</italic>â=â1.39Ã10<sup>â4</sup>) were significantly associated with LOAD risk in the Japanese Stage 1 dataset (<xref ref-type="table" rid="pone-0058618-t004">Table 4</xref>). Nominally significant associations were also observed for SNPs in <italic>CR1, CLU,</italic> and <italic>ABCA7.</italic> Of the eight SNPs tested in the small Korean sample, nominally signficant results (<italic>P</italic>&lt;0.05) were obtained for one SNP in <italic>CLU</italic> and <italic>PICALM,</italic> each with the same pattern of association and comparable effect size as in Japanese.</p>
      <table-wrap id="pone-0058618-t004" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0058618.t004</object-id>
        <label>Table 4</label>
        <caption>
          <title>Association of LOAD in Asians with SNPs showing genome-wide significance in Caucasians.</title>
        </caption>
        <alternatives>
          <graphic id="pone-0058618-t004-4" xlink:href="pone.0058618.t004"/>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" rowspan="1" colspan="1">Gene</td>
                <td align="left" rowspan="1" colspan="1">CH</td>
                <td align="left" rowspan="1" colspan="1">BP</td>
                <td align="left" rowspan="1" colspan="1">SNP</td>
                <td align="left" rowspan="1" colspan="1">MA</td>
                <td colspan="3" align="left" rowspan="1">Japanese</td>
                <td colspan="3" align="left" rowspan="1">Korean</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">MAF</td>
                <td align="left" rowspan="1" colspan="1">P</td>
                <td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">MAF</td>
                <td align="left" rowspan="1" colspan="1">P</td>
                <td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">CR1</td>
                <td align="left" rowspan="1" colspan="1">1</td>
                <td align="left" rowspan="1" colspan="1">207,692,049</td>
                <td align="left" rowspan="1" colspan="1">rs6656401</td>
                <td align="left" rowspan="1" colspan="1">A</td>
                <td align="left" rowspan="1" colspan="1">0.04</td>
                <td align="left" rowspan="1" colspan="1">
<bold><italic>9.02E-03</italic></bold>
</td>
                <td align="left" rowspan="1" colspan="1">1.38 (1.08â1.76)</td>
                <td align="left" rowspan="1" colspan="1">0.04</td>
                <td align="left" rowspan="1" colspan="1">3.75Eâ01</td>
                <td align="left" rowspan="1" colspan="1">1.24 (0.77â1.99)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CR1</td>
                <td align="left" rowspan="1" colspan="1">1</td>
                <td align="left" rowspan="1" colspan="1">207,784,968</td>
                <td align="left" rowspan="1" colspan="1">rs3818361</td>
                <td align="left" rowspan="1" colspan="1">A</td>
                <td align="left" rowspan="1" colspan="1">0.39</td>
                <td align="left" rowspan="1" colspan="1">2.54Eâ01</td>
                <td align="left" rowspan="1" colspan="1">0.94 (0.85â1.04)</td>
                <td align="left" rowspan="1" colspan="1">0.31</td>
                <td align="left" rowspan="1" colspan="1">4.08Eâ01</td>
                <td align="left" rowspan="1" colspan="1">0.92 (0.76â1.12)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">BIN1</td>
                <td align="left" rowspan="1" colspan="1">2</td>
                <td align="left" rowspan="1" colspan="1">127,894,615</td>
                <td align="left" rowspan="1" colspan="1">rs744373</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.33</td>
                <td align="left" rowspan="1" colspan="1">
<bold><italic>1.39E</italic></bold>
<bold>â</bold>
<bold><italic>04</italic></bold>
</td>
                <td align="left" rowspan="1" colspan="1">1.25 (1.11â1.4)</td>
                <td align="left" rowspan="1" colspan="1">0.36</td>
                <td align="left" rowspan="1" colspan="1">8.05Eâ01</td>
                <td align="left" rowspan="1" colspan="1">0.98 (0.81â1.18)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CD2AP</td>
                <td align="left" rowspan="1" colspan="1">6</td>
                <td align="left" rowspan="1" colspan="1">47,453,378</td>
                <td align="left" rowspan="1" colspan="1">rs9349407</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.14</td>
                <td align="left" rowspan="1" colspan="1">3.83Eâ01</td>
                <td align="left" rowspan="1" colspan="1">0.94 (0.82â1.08)</td>
                <td align="left" rowspan="1" colspan="1">NT</td>
                <td align="left" rowspan="1" colspan="1">â</td>
                <td align="left" rowspan="1" colspan="1">â</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">EPHA1</td>
                <td align="left" rowspan="1" colspan="1">7</td>
                <td align="left" rowspan="1" colspan="1">143,109,139</td>
                <td align="left" rowspan="1" colspan="1">rs11767557</td>
                <td align="left" rowspan="1" colspan="1">C</td>
                <td align="left" rowspan="1" colspan="1">0.17</td>
                <td align="left" rowspan="1" colspan="1">6.47Eâ01</td>
                <td align="left" rowspan="1" colspan="1">1.03 (0.9â1.17)</td>
                <td align="left" rowspan="1" colspan="1">NT</td>
                <td align="left" rowspan="1" colspan="1">â</td>
                <td align="left" rowspan="1" colspan="1">â</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CLU</td>
                <td align="left" rowspan="1" colspan="1">8</td>
                <td align="left" rowspan="1" colspan="1">27,456,253</td>
                <td align="left" rowspan="1" colspan="1">rs2279590</td>
                <td align="left" rowspan="1" colspan="1">T</td>
                <td align="left" rowspan="1" colspan="1">0.25</td>
                <td align="left" rowspan="1" colspan="1">
<bold><italic>7.01E</italic></bold>
<bold>â</bold>
<bold><italic>03</italic></bold>
</td>
                <td align="left" rowspan="1" colspan="1">0.85 (0.76â0.96)</td>
                <td align="left" rowspan="1" colspan="1">0.2</td>
                <td align="left" rowspan="1" colspan="1">9.70Eâ02</td>
                <td align="left" rowspan="1" colspan="1">0.82 (0.65â1.04)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CLU</td>
                <td align="left" rowspan="1" colspan="1">8</td>
                <td align="left" rowspan="1" colspan="1">27,464,519</td>
                <td align="left" rowspan="1" colspan="1">rs11136000</td>
                <td align="left" rowspan="1" colspan="1">T</td>
                <td align="left" rowspan="1" colspan="1">0.28</td>
                <td align="left" rowspan="1" colspan="1">
<bold><italic>1.09E</italic></bold>
<bold>â</bold>
<bold><italic>02</italic></bold>
</td>
                <td align="left" rowspan="1" colspan="1">0.87 (0.78â0.97)</td>
                <td align="left" rowspan="1" colspan="1">0.23</td>
                <td align="left" rowspan="1" colspan="1">
<bold><italic>3.61E</italic></bold>
<bold>â</bold>
<bold><italic>02</italic></bold>
</td>
                <td align="left" rowspan="1" colspan="1">0.79 (0.63â0.98)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CLU</td>
                <td align="left" rowspan="1" colspan="1">8</td>
                <td align="left" rowspan="1" colspan="1">27,468,862</td>
                <td align="left" rowspan="1" colspan="1">rs9331888</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.41</td>
                <td align="left" rowspan="1" colspan="1">6.97Eâ02</td>
                <td align="left" rowspan="1" colspan="1">1.1 (0.99â1.22)</td>
                <td align="left" rowspan="1" colspan="1">0.47</td>
                <td align="left" rowspan="1" colspan="1">1.92Eâ01</td>
                <td align="left" rowspan="1" colspan="1">0.89 (0.74â1.06)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MS4A6A</td>
                <td align="left" rowspan="1" colspan="1">11</td>
                <td align="left" rowspan="1" colspan="1">59,939,307</td>
                <td align="left" rowspan="1" colspan="1">rs610932</td>
                <td align="left" rowspan="1" colspan="1">T</td>
                <td align="left" rowspan="1" colspan="1">0.3</td>
                <td align="left" rowspan="1" colspan="1">7.99Eâ01</td>
                <td align="left" rowspan="1" colspan="1">0.99 (0.89â1.1)</td>
                <td align="left" rowspan="1" colspan="1">NT</td>
                <td align="left" rowspan="1" colspan="1">â</td>
                <td align="left" rowspan="1" colspan="1">â</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MS4A6A</td>
                <td align="left" rowspan="1" colspan="1">11</td>
                <td align="left" rowspan="1" colspan="1">59,971,795</td>
                <td align="left" rowspan="1" colspan="1">rs670139</td>
                <td align="left" rowspan="1" colspan="1">T</td>
                <td align="left" rowspan="1" colspan="1">0.4</td>
                <td align="left" rowspan="1" colspan="1">8.23Eâ01</td>
                <td align="left" rowspan="1" colspan="1">0.99 (0.89â1.09)</td>
                <td align="left" rowspan="1" colspan="1">NT</td>
                <td align="left" rowspan="1" colspan="1">â</td>
                <td align="left" rowspan="1" colspan="1">â</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MS4A6A</td>
                <td align="left" rowspan="1" colspan="1">11</td>
                <td align="left" rowspan="1" colspan="1">60,034,429</td>
                <td align="left" rowspan="1" colspan="1">rs4938933</td>
                <td align="left" rowspan="1" colspan="1">C</td>
                <td align="left" rowspan="1" colspan="1">0.27</td>
                <td align="left" rowspan="1" colspan="1">3.23Eâ01</td>
                <td align="left" rowspan="1" colspan="1">1.06 (0.95â1.18)</td>
                <td align="left" rowspan="1" colspan="1">NT</td>
                <td align="left" rowspan="1" colspan="1">â</td>
                <td align="left" rowspan="1" colspan="1">â</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PICALM</td>
                <td align="left" rowspan="1" colspan="1">11</td>
                <td align="left" rowspan="1" colspan="1">85,868,640</td>
                <td align="left" rowspan="1" colspan="1">rs3851179</td>
                <td align="left" rowspan="1" colspan="1">T</td>
                <td align="left" rowspan="1" colspan="1">0.39</td>
                <td align="left" rowspan="1" colspan="1">
<bold><italic>1.71E</italic></bold>
<bold>â</bold>
<bold><italic>05</italic></bold>
</td>
                <td align="left" rowspan="1" colspan="1">0.8 (0.73â0.89)</td>
                <td align="left" rowspan="1" colspan="1">0.34</td>
                <td align="left" rowspan="1" colspan="1">
<bold><italic>1.99E</italic></bold>
<bold>â</bold>
<bold><italic>02</italic></bold>
</td>
                <td align="left" rowspan="1" colspan="1">0.79 (0.66â0.96)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">ABCA7</td>
                <td align="left" rowspan="1" colspan="1">19</td>
                <td align="left" rowspan="1" colspan="1">1,046,520</td>
                <td align="left" rowspan="1" colspan="1">rs3764650</td>
                <td align="left" rowspan="1" colspan="1">G</td>
                <td align="left" rowspan="1" colspan="1">0.42</td>
                <td align="left" rowspan="1" colspan="1">
<bold><italic>3.66E</italic></bold>
<bold>â</bold>
<bold><italic>02</italic></bold>
</td>
                <td align="left" rowspan="1" colspan="1">1.13 (1.01â1.27)</td>
                <td align="left" rowspan="1" colspan="1">NT</td>
                <td align="left" rowspan="1" colspan="1">â</td>
                <td align="left" rowspan="1" colspan="1">â</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">EXOC3L2</td>
                <td align="left" rowspan="1" colspan="1">19</td>
                <td align="left" rowspan="1" colspan="1">45,708,888</td>
                <td align="left" rowspan="1" colspan="1">rs597668</td>
                <td align="left" rowspan="1" colspan="1">C</td>
                <td align="left" rowspan="1" colspan="1">0.43</td>
                <td align="left" rowspan="1" colspan="1">
<bold><italic>8.23E</italic></bold>
<bold>â</bold>
<bold><italic>03</italic></bold>
</td>
                <td align="left" rowspan="1" colspan="1">0.88 (0.79â0.97)</td>
                <td align="left" rowspan="1" colspan="1">0.37</td>
                <td align="left" rowspan="1" colspan="1">7.31Eâ01</td>
                <td align="left" rowspan="1" colspan="1">0.97 (0.8â1.17)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CD33</td>
                <td align="left" rowspan="1" colspan="1">19</td>
                <td align="left" rowspan="1" colspan="1">51,727,962</td>
                <td align="left" rowspan="1" colspan="1">rs3865444</td>
                <td align="left" rowspan="1" colspan="1">A</td>
                <td align="left" rowspan="1" colspan="1">0.2</td>
                <td align="left" rowspan="1" colspan="1">4.92Eâ01</td>
                <td align="left" rowspan="1" colspan="1">1.04 (0.92â1.18)</td>
                <td align="left" rowspan="1" colspan="1">NT</td>
                <td align="left" rowspan="1" colspan="1">â</td>
                <td align="left" rowspan="1" colspan="1">â</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="nt104">
            <label/>
            <p>NT not tested; P&lt;0.05 was italized.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>Our multi-stage GWAS of LOAD identified for the first-time genome-wide significant association with <italic>SORL1</italic>. Genetic association with <italic>SORL1</italic> was first established in a study focused on genes encoding proteins involved in vacuolar protein sorting <xref rid="pone.0058618-Rogaeva1" ref-type="bibr">[19]</xref>. Most, but not all, subsequent studies in Caucsians replicated this finding (summarized in Alzgene database: <ext-link ext-link-type="uri" xlink:href="http://www.alzgene.org/">http://www.alzgene.org/</ext-link>). Confirmatory evidence of association with <italic>SORL1</italic> SNPs has also been reported in comparatively small samples of Chinese and Japanese (reviewed in <xref rid="pone.0058618-Reitz1" ref-type="bibr">[20]</xref>). These findings are independent of previous candidate gene studies of <italic>SORL1</italic> in Japanese (two subjects in common) and with Caucasians in the Rogaeva et al. study <xref rid="pone.0058618-Rogaeva1" ref-type="bibr">[19]</xref> (less than 2% overlap).</p>
      <p>The two genome-wide significant <italic>SORL1</italic> SNPs, rs11218343 and rs3781834 are located at chromosome positions 121,435,587 base pairs and 121,445,940 base pairs, respectively, and thus between the two previously reported strongly associated 3-marker haplotypes that extend upstream from rs641120 (121,380,965 base pairs) and downstream from rs1699102 (121,456,962 base pairs) <xref rid="pone.0058618-Rogaeva1" ref-type="bibr">[19]</xref>. A recent meta-analysis including more than 30,000 Caucasian and Asian subjects demonstrated that multiple <italic>SORL1</italic> SNPs in distinct regions are associated with AD <xref rid="pone.0058618-Reitz1" ref-type="bibr">[20]</xref>, a finding substantiated in an association study of <italic>SORL1</italic> SNPs with brain MRI traits in LOAD families <xref rid="pone.0058618-Cuenco1" ref-type="bibr">[21]</xref>. Further analysis of our large Caucasian sample suggests that the association peak at rs3781834 is independent of at least one of the two distinct haplotypes previously associated with AD in an independent sample of non-Hispanic Caucasians, Caribbean Hispanics and Israeli-Arabs (<xref ref-type="supplementary-material" rid="pone.0058618.s005">Fig. S5</xref>) <xref rid="pone.0058618-Rogaeva1" ref-type="bibr">[19]</xref>, Since all of the SNPs at the association peaks reported in this study and previously are intronic, functional studies are required to determine the identity of pathogenic variants at these locations.</p>
      <p>Remarkably, the less frequent alleles at rs11218343 and rs3781834 are protective in both Japanese and Caucasian datasets with very similar odds ratios (range 0.74 to 0.83) despite the fact that these alleles are much rarer in Caucasians (4% and 2%, respectively) than in Japanese (34% and 23%, respectively). The rarity of these SNPs in Caucasians, as well as allelic heterogeneity, may explain why <italic>SORL1</italic> did not previously emerged as a genome-wide significant AD locus in much larger GWAS <xref rid="pone.0058618-Hollingworth1" ref-type="bibr">[4]</xref>, <xref rid="pone.0058618-Naj1" ref-type="bibr">[5]</xref>. Given the discovery sample size, effect size (odds ratio [OR] â=â0.74) and MAF (0.23) of the top <italic>SORL1</italic> SNP (rs3781834) in the Japanese sample, and a significance level of 2Ã10<sup>â5</sup> (i.e., threshold for including a SNP in the Stage 2 replication phase), calculation of power <italic>post hoc</italic> using the PAWE-3D program <xref rid="pone.0058618-Gordon1" ref-type="bibr">[22]</xref> confirmed that the discovery sample had sufficient power (83.7%). By comparison, the Caucasian sample of 22,771 subjects had only 52.8% power to detect association with this SNP at the observed significance level of 7.9Ã10<sup>â4</sup> and OR (0.78) and a much lower MAF (0.02) than in Japanese.</p>
      <p>The most significant result in the GWAS in Japanese was obtained for <italic>PALM2</italic> SNP rs913360 (<italic>P</italic>â=â1.8Ã10<sup>â7</sup>), but this SNP was not significant in the Japanese replication sample (<italic>P</italic>â=â0.16) and the result for the combined Japanese datasets was less significant than in the discovery sample (<italic>P</italic>â=â6.6Ã10<sup>â6</sup>). There was no evidence in the large Caucasian dataset supporting association for rs913360 (<italic>P</italic>â=â0.38) or other <italic>PALM2</italic> SNPs.</p>
      <p>We obtained evidence in Japanese and Korean populations for association of AD with the same SNPs in the <italic>PICALM</italic> and <italic>BIN1</italic> regions that were identified as genome-wide significant in multiple large GWAS in Caucasians <xref rid="pone.0058618-Hollingworth1" ref-type="bibr">[4]</xref>, <xref rid="pone.0058618-Naj1" ref-type="bibr">[5]</xref>. There are no previously reported association studies of these loci in Japanese. Several small association studies of <italic>PICALM</italic> in comparatively smaller Chinese samples have yielded conflicting results <xref rid="pone.0058618-Li2" ref-type="bibr">[23]</xref>â<xref rid="pone.0058618-Chen1" ref-type="bibr">[25]</xref>. We also found nominally significant associations in the Japanese sample for previously associated SNPs in <italic>CR1, CLU,</italic> and <italic>ABCA7.</italic> Lack of asociation with <italic>EPHA1, CD2AP, MS4A6A,</italic> and <italic>CD33</italic> may be due to insufficient power, different linkage disequilibrium structure of these regions than in Caucasisans, locus heterogeneity or intragenic heterogeneity.</p>
      <p>In addition, our analyses showed numerous highly significant results for imputed SNPs in the <italic>APOE</italic> region (including <italic>CEACAM/BCL3, PVRL2, TOMM40,</italic> and <italic>LOC284352)</italic> even after adjustment for the dose of the Îµ4 allele. However, recognizing that the reliability of imputation is poor for SNPs in this region <xref rid="pone.0058618-Jun1" ref-type="bibr">[13]</xref>, we genotyped 10 of the significant SNPs in the Japanese discovery and replication datasets. Only one of these results, a <italic>PPP1R37</italic> SNP, was nominally significant after adjustment for dose of Îµ4. Association of AD with this SNP, which is located approximately 225 kb from <italic>APOE</italic>, has not been observed previously. <italic>PVRL2</italic> and <italic>APOE</italic> are located in a genomic region sandwiched between two recombination hotspots <xref rid="pone.0058618-Takei1" ref-type="bibr">[26]</xref>, where strong association signals for LOAD have been reproducibly detected in Caucasians <xref rid="pone.0058618-ErtekinTaner1" ref-type="bibr">[1]</xref>, <xref rid="pone.0058618-Naj1" ref-type="bibr">[5]</xref>, but dissipate almost completely for all non-<italic>APOE</italic> loci after conditioning on <italic>APOE</italic>, suggesting that no other loci in this region influence LOAD susceptibility <xref rid="pone.0058618-Jun1" ref-type="bibr">[13]</xref>. This conclusion is consistent with the observation of moderate linkage disequilibrium between the SNPs determining <italic>APOE</italic> genotype, rs7412 and rs429358 (<xref ref-type="supplementary-material" rid="pone.0058618.s005">Fig. S5</xref>), SNPs showing genomewide significant evidence for association with LOAD without adjustment for <italic>APOE</italic> genotype, and our prior LOAD association studies with SNPs in this region among Caucasians <xref rid="pone.0058618-Jun1" ref-type="bibr">[13]</xref>.</p>
      <p>SorL1, also known as SorLA and LR11, and APP proteins are co-localized in the endosomal and Golgi compartments <xref rid="pone.0058618-Andersen1" ref-type="bibr">[27]</xref>. SorL1 through its co-dependent interaction with vps26 regulates the intracellular transport and processing of APP, resulting in reduction of amyloid beta (AÃ) peptide production <xref rid="pone.0058618-Reitz1" ref-type="bibr">[20]</xref>, <xref rid="pone.0058618-Andersen1" ref-type="bibr">[27]</xref>, <xref rid="pone.0058618-Fjorback1" ref-type="bibr">[28]</xref>. <italic>SORL1</italic> knock-out mice carrying both pathogenic mutations in the <italic>PSEN1</italic> (exon 9 deletion) and <italic>APP</italic> (Swedish, K595M/N596L) exhibited increased production and accumulation of AÃ <xref rid="pone.0058618-Dodson1" ref-type="bibr">[29]</xref>. <italic>SORL1</italic> variants might influence the CSF AÃ42 level in AD patients <xref rid="pone.0058618-Klsch1" ref-type="bibr">[30]</xref>. Recently, Pottier et al. sequenced the exomes of 29 index cases with autosomal dominant early-onset AD who lacked mutations in <italic>APP, PSEN1</italic> and <italic>PSEN2</italic>
<xref rid="pone.0058618-Pottier1" ref-type="bibr">[2]</xref>. Seven of these subjects had private <italic>SORL1</italic> mutations (2 nonsense and 2 missense) that were predicted to have a pathogenic effect. By comparison, the two genome-wide significant SNPs in this study are both intronic. It is expected that future large resequencing studies of <italic>SORL1</italic> will identify the functional variants, thus providing important clues about the mechanisms governing normal and abnormal action of SorL1 on processes leading to LOAD. The emergence of <italic>SORL1</italic> as a genome-wide significant locus for AD confirms existing genetic and functional evidence and elevates the importance of intracellular trafficking involving retromer and the Golgi-to- endosome as a key pathway leading to AD <xref rid="pone.0058618-Vardarajan1" ref-type="bibr">[31]</xref>, <xref rid="pone.0058618-Choy1" ref-type="bibr">[32]</xref>.</p>
    </sec>
    <sec sec-type="supplementary-material" id="s5">
      <title>Supporting Information</title>
      <supplementary-material content-type="local-data" id="pone.0058618.s001">
        <label>Figure S1</label>
        <caption>
          <p>
<bold>Quantile-quantile (Q-Q) plot of observed (y-axis) vs. expected (x-axis) </bold>
<bold><italic>P</italic></bold>
<bold>-values from tests of association genome-wide (5,877,918 SNPs) adjusted for population structure, age and sex for LOAD in the Japanese discovery sample.</bold> Genomic inflation was low (Î»â=â1.047).</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pone.0058618.s001.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0058618.s002">
        <label>Figure S2</label>
        <caption>
          <p>
<bold>Manhattan plot of observed âlog<sub>10</sub></bold>
<bold><italic>P</italic></bold>
<bold>-values for genome-wide SNP association tests for LOAD (y-axis) according to chromosomal location (x-axis) in the Japanese discovery sample adjusted for population structure, age, and sex.</bold> All genome-wide significant SNPs (above the horizontal line corresponding to <italic>Pâ=â</italic>5Ã10<sup>â8</sup> on the y-axis) are located in the <italic>APOE</italic> region on chromosome 19.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pone.0058618.s002.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0058618.s003">
        <label>Figure S3</label>
        <caption>
          <p>
<bold>Linkage disequilibrium (r<sup>2</sup>) among SNPs in the </bold>
<bold><italic>APOE</italic></bold>
<bold> region genotyped using TaqMan calculated in the Japanese discovery (A) and replication (B) datasets.</bold>
<italic>APOE</italic> genotype is derived from haplotypes of coding SNPs rs429358 and rs7412.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pone.0058618.s003.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0058618.s004">
        <label>Figure S4</label>
        <caption>
          <p>
<bold>Linkage disequilibrium (r<sup>2</sup>) among SNPs in the </bold>
<bold><italic>SORL1</italic></bold>
<bold> region genotyped in the Japanese discovery (A) and replication (B) datasets.</bold>
</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pone.0058618.s004.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0058618.s005">
        <label>Figure S5</label>
        <caption>
          <p>
<bold>Comparison of </bold>
<bold><italic>SORL1</italic></bold>
<bold> association findings in the current study with association signals previously identified by Rogaeva et al.</bold>
<xref rid="pone.0058618-Reitz1" ref-type="bibr">[<bold>20</bold>]</xref>
<bold>.</bold> (<bold>A</bold>) Regional association plot of the <italic>SORL1</italic> region. P-values are expressed as âlog<sub>10</sub>(P) (y-axis) for every tested SNP ordered by chromosomal location (x-axis) and represented as blue rectangles for the Japanese discovery set (J1), light blue diamonds for the ADGC Caucasian set (C), pink circles for meta-analysis of Japanese discovery and Caucasian sets (J1+C), and red circles for meta-analysis of Japanese discovery, Japanese replication (J2), Korean (K), and Caucasian sets (J1+J2+K+C). The numbers below the line showing the orientation of <italic>SORL1</italic> are the designations for associated SNPs in the Rogaeva et al. study: 8â=ârs668387, 9â=ârs689021, 10â=ârs641120, 11â=ârs4935775, 19â=ârs2070045, 22â=ârs1699102, 23â=ârs3824968, 24â=ârs2282649, and 25â=ârs1010159. Recombination hotspots are indicated by the continuous blue line behind the symbols for the SNP P-values. (<bold>B</bold>) Linkage disequilibrium (r<sup>2</sup>) of the previously associated SNPs in the <italic>SORL1</italic> region <xref rid="pone.0058618-Reitz1" ref-type="bibr">[20]</xref> in the HapMap 2 reference Japanese population (JPT). The association signal with rs3781834 (contained in Block 2) appears to be independent of one of the distinct AD-associated haplotypes reported by Rogaeva et al. <xref rid="pone.0058618-Reitz1" ref-type="bibr">[20]</xref> (including SNPs in Block 1), but not necessarily independent of the other AD-associated haplotype reported by Rogaeva et al which includes rs1699102 in Block 2 and the SNPs in Block 3.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pone.0058618.s005.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0058618.s006">
        <label>Table S1</label>
        <caption>
          <p>
<bold>Top-ranked GWAS results in the Japanese GWAS dataset (P&lt;1Ã10</bold>
<sup>â<bold>4</bold></sup>
<bold> and imputation quality</bold> â¥<bold>0.8) with and withut adjustment for the number of </bold>
<bold><italic>APOE</italic></bold>
<bold> Îµ4 alleles.</bold>
</p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0058618.s006.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0058618.s007">
        <label>Table S2</label>
        <caption>
          <p>
<bold>Association of individually genotyped SNPs in the </bold>
<bold><italic>APOE</italic></bold>
<bold> region in models with and without adjustment for the number of </bold>
<bold><italic>APOE</italic></bold>
<bold> Îµ4 alleles.</bold>
</p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0058618.s007.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0058618.s008">
        <label>Table S3</label>
        <caption>
          <p>
<bold>Association results for </bold>
<bold><italic>SORL1</italic></bold>
<bold> SNPs genotyped in the Japanese replication sample.</bold>
</p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0058618.s008.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We deeply thank all the patients with AD and their families, and the control individuals for their participation in this study. Without their contribution, this study would have been impossible. We acknowledge the valuable contributions of Drs. Satoshi Takahashi and Yoshikatsu Fujisawa who died before publication of this paper. We also thank Drs. D. Stephen Snyder and Marilyn Miller from NIA who are <italic>ex-officio</italic> ADGC members.</p>
      <p>
<bold>Alzheimerâs Disease Genetics Consortium authors and affiliations</bold>
</p>
      <p>Marilyn S. Albert<sup>1</sup>, Roger L. Albin<sup>2,3</sup>, Liana G. Apostolova<sup>4</sup>, Steven E. Arnold<sup>5</sup>, Clinton T. Baldwin<sup>6</sup>, Robert Barber<sup>7</sup>, Michael M. Barmada<sup>8</sup>, Lisa L. Barnes<sup>9,10</sup>, Thomas G. Beach<sup>11</sup>, Gary W. Beecham<sup>12,13</sup>, Duane Beekly<sup>14</sup>, David A. Bennett<sup>9,15</sup>, Eileen H. Bigio<sup>16</sup>, Thomas D. Bird<sup>17</sup>, Deborah Blacker<sup>18,19</sup>, Bradley F. Boeve<sup>20</sup>, James D. Bowen<sup>21</sup>, Adam Boxer<sup>22</sup>, James R. Burke<sup>23</sup>, Joseph D. Buxbaum<sup>24-26</sup>, Nigel J. Cairns<sup>27</sup>, Laura B. Cantwell<sup>28</sup>, Chuanhai Cao<sup>29</sup>, Chris S. Carlson<sup>30</sup>, Regina M. Carney<sup>31</sup>, Minerva M. Carrasquillo<sup>32</sup>, Steven L. Carroll<sup>33</sup>, Helena C. Chui<sup>34</sup>, David G. Clark<sup>35</sup>, Jason Corneveaux<sup>36</sup>, Paul K. Crane<sup>37</sup>, David H. Cribbs<sup>38</sup>, Elizabeth A. Crocco<sup>39</sup>, Carlos Cruchaga<sup>40</sup>, Philip L. De Jager<sup>41,42</sup>, Charles DeCarli<sup>43</sup>, Steven T. DeKosky<sup>44</sup>, F. Yesim Demirci<sup>8</sup>, Malcolm Dick<sup>45</sup>, Dennis W. Dickson<sup>32</sup>, Ranjan Duara<sup>46</sup>, Nilufer Ertekin-Taner<sup>32,47</sup>, Denis Evans<sup>48</sup>, Kelley M. Faber<sup>49</sup>, Kenneth B. Fallon<sup>33</sup>, Martin R. Farlow<sup>50</sup>, Steven Ferris<sup>51</sup>, Tatiana M. Foroud<sup>49</sup>, Matthew P. Frosch<sup>52</sup>, Douglas R. Galasko<sup>53</sup>, Mary Ganguli<sup>54</sup>, Marla Gearing<sup>55,56</sup>, Daniel H. Geschwind<sup>57</sup>, Bernardino Ghetti<sup>58</sup>, John R. Gilbert<sup>12,13</sup>, Sid Gilman<sup>2</sup>, Jonathan D. Glass<sup>59</sup>, Alison M. Goate<sup>40</sup>, Neill R. Graff-Radford<sup>32,47</sup>, Robert C. Green<sup>60</sup>, John H. Growdon<sup>61</sup>, Hakon Hakonarson<sup>62</sup>, Kara L. Hamilton-Nelson<sup>12</sup>, Ronald L. Hamilton<sup>63</sup>, John Hardy<sup>64</sup>, Lindy E. Harrell<sup>35</sup>, Elizabeth Head<sup>65</sup>, Lawrence S. Honig<sup>66</sup>, Matthew J. Huentelman<sup>36</sup>, Christine M. Hulette<sup>67</sup>, Bradley T. Hyman<sup>61</sup>, Gail P. Jarvik<sup>68,69</sup>, Gregory A. Jicha<sup>70</sup>, Lee-Way Jin<sup>71</sup>, M. Ilyas Kamboh<sup>8,72</sup>, Anna Karydas<sup>22</sup>, John S.K. Kauwe<sup>73</sup>, Jeffrey A. Kaye<sup>74,75</sup>, Ronald Kim<sup>76</sup>, Edward H. Koo<sup>53</sup>, Neil W. Kowall<sup>77,78</sup>, Joel H. Kramer<sup>79</sup>, Patricia Kramer<sup>74,80</sup>, Walter A. Kukull<sup>81</sup>, Frank M. LaFerla<sup>82</sup>, James J. Lah<sup>59</sup>, Eric B. Larson<sup>37,83</sup>, James B. Leverenz<sup>84</sup>, Allan I. Levey<sup>59</sup>, Ge Li<sup>85</sup>, Chiao-Feng Lin<sup>28</sup>, Andrew P. Lieberman<sup>86</sup>, Oscar L. Lopez<sup>72</sup>, Kathryn L. Lunetta<sup>87</sup>, Constantine G. Lyketsos<sup>88</sup>, Wendy J. Mack<sup>89</sup>, Daniel C. Marson35, Eden R. Martin<sup>12,13</sup>, Frank Martiniuk<sup>90</sup>, Deborah C. Mash<sup>91</sup>, Eliezer Masliah<sup>53,92</sup>, Wayne C. McCormick<sup>37</sup>, Susan M. McCurry<sup>93</sup>, Andrew N. McDavid<sup>30</sup>, Ann C. McKee<sup>77,78</sup>, Marsel Mesulam<sup>94</sup>, Bruce L. Miller<sup>22</sup>, Carol A. Miller<sup>95</sup>, Joshua W. Miller<sup>71</sup>, Thomas J. Montine<sup>84</sup>, John C. Morris<sup>27,96</sup>, Jill R. Murrell<sup>49,58</sup>, Amanda J. Myers<sup>39</sup>, Adam C. Naj<sup>12</sup>, John M. Olichney<sup>43</sup>, Vernon S. Pankratz<sup>97</sup>, Joseph E. Parisi<sup>98,99</sup>, Elaine Peskind<sup>85</sup>, Ronald C. Petersen<sup>20</sup>, Aimee Pierce<sup>38</sup>, Wayne W. Poon<sup>45</sup>, Huntington Potter<sup>29</sup>, Joseph F. Quinn<sup>74</sup>, Ashok Raj<sup>29</sup>, Ruchita A. Rajbhandary<sup>12</sup>, Murray Raskind<sup>85</sup>, Eric M. Reiman<sup>36,100-102</sup>, Barry Reisberg<sup>51,103</sup>, Christiane Reitz<sup>66,104,105</sup>, John M. Ringman<sup>4</sup>, Erik D. Roberson<sup>35</sup>, Ekaterina Rogaeva<sup>106</sup>, Howard J. Rosen<sup>22</sup>, Roger N. Rosenberg<sup>107</sup>, Mary Sano<sup>25</sup>, Andrew J. Saykin<sup>49,108</sup>, Julie A. Schneider<sup>9,109</sup>, Lon S. Schneider<sup>34,110</sup>, William W. Seeley<sup>22</sup>, Amanda G. Smith<sup>29</sup>, Joshua A. Sonnen<sup>84</sup>, Salvatore Spina<sup>58</sup>, Robert A. Stern<sup>77</sup>, Rudolph E. Tanzi<sup>61</sup>, John Q. Trojanowski<sup>28</sup>, Juan C. Troncoso<sup>111</sup>, Debby W. Tsuang<sup>85</sup>, Otto Valladares<sup>28</sup>, Vivianna M. Van Deerlin<sup>28</sup>, Linda J. Van Eldik<sup>112</sup>, Badri N. Vardarajan<sup>6</sup>, Harry V. Vinters<sup>4,113</sup>, Jean Paul Vonsattel<sup>114</sup>, Sandra Weintraub<sup>94</sup>, Kathleen A. Welsh-Bohmer<sup>23,115</sup>, Jennifer Williamson<sup>66</sup>, Randall L. Woltjer<sup>116</sup>, Clinton B. Wright<sup>117</sup>, Steven G. Younkin<sup>32</sup>, Chang-En Yu<sup>37</sup>, Lei Yu<sup>9</sup>.</p>
      <p>1 Department of Neurology, Johns Hopkins University, Baltimore, Maryland.</p>
      <p>2 Department of Neurology, University of Michigan, Ann Arbor, Michigan.</p>
      <p>3 Geriatric Research, Education and Clinical Center (GRECC)., VA Ann Arbor Healthcare System (VAAAHS), Ann Arbor, Michigan.</p>
      <p>4 Department of Neurology, University of California Los Angeles, Los Angeles, California.</p>
      <p>5 Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.</p>
      <p>6 Department of Medicine (Genetics Program), Boston University, Boston, Massachusetts.</p>
      <p>7 Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas.</p>
      <p>8 Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania.</p>
      <p>9 Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois.</p>
      <p>10 Department of Behavioral Sciences, Rush University Medical Center, Chicago, Illinois.</p>
      <p>11 Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Phoenix, Arizona.</p>
      <p>12 The John P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida.</p>
      <p>13 Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miami, Florida.</p>
      <p>14 National Alzheimer's Coordinating Center, University of Washington, Seattle, Washington.</p>
      <p>15 Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.</p>
      <p>16 Department of Pathology, Northwestern University, Chicago, Illinois.</p>
      <p>17 Department of Neurology, University of Washington, Seattle, Washington.</p>
      <p>18 Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.</p>
      <p>19 Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts.</p>
      <p>20 Department of Neurology, Mayo Clinic, Rochester, Minnesota.</p>
      <p>21 Swedish Medical Center, Seattle, Washington.</p>
      <p>22 Department of Neurology, University of California San Francisco, San Fransisco, California.</p>
      <p>23 Department of Medicine, Duke University, Durham, North Carolina.</p>
      <p>24 Department of Neuroscience, Mount Sinai School of Medicine, New York.</p>
      <p>25 Department of Psychiatry, Mount Sinai School of Medicine, New York.</p>
      <p>26 Departments of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York.</p>
      <p>27 Department of Pathology and Immunology, Washington University, St. Louis, Missouri.</p>
      <p>28 Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.</p>
      <p>29 USF Health Byrd Alzheimer's Institute, University of South Florida, Tampa, Florida.</p>
      <p>30 Fred Hutchinson Cancer Research Center, Seattle, Washington.</p>
      <p>31 Department of Psychiatry, Vanderbilt University, Nashville, Tennessee.</p>
      <p>32 Department of Neuroscience, Mayo Clinic, Jacksonville, Florida.</p>
      <p>33 Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.</p>
      <p>34 Department of Neurology, University of Southern California, Los Angeles, California.</p>
      <p>35 Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama.</p>
      <p>36 Neurogenomics Division, Translational Genomics Research Institute, Phoenix, Arizona.</p>
      <p>37 Department of Medicine, University of Washington, Seattle, Washington.</p>
      <p>38 Department of Neurology, University of California Irvine, Irvine, California.</p>
      <p>39 Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, Florida.</p>
      <p>40 Department of Psychiatry and Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University School of Medicine, St. Louis, Missouri.</p>
      <p>41 Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Department of Neurology &amp; Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</p>
      <p>42 Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts.</p>
      <p>43 Department of Neurology, University of California Davis, Sacramento, California.</p>
      <p>44 University of Virginia School of Medicine, Charlottesville, Virginia.</p>
      <p>45 Institute for Memory Impairments and Neurological Disorders, University of California Irvine, Irvine, California.</p>
      <p>46 Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, Florida.</p>
      <p>47 Department of Neurology, Mayo Clinic, Jacksonville, Florida.</p>
      <p>48 Rush Institute for Healthy Aging, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois.</p>
      <p>49 Department of Medical and Molecular Genetics, Indiana University, Indianapolis, Indiana.</p>
      <p>50 Department of Neurology, Indiana University, Indianapolis, Indiana.</p>
      <p>51 Department of Psychiatry, New York University, New York.</p>
      <p>52 C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, Charlestown, Massachusetts.</p>
      <p>53 Department of Neurosciences, University of California San Diego, La Jolla, California.</p>
      <p>54 Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.</p>
      <p>55 Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia.</p>
      <p>56 Emory Alzheimer's Disease Center, Emory University, Atlanta, Georgia.</p>
      <p>57 Neurogenetics Program, University of California Los Angeles, Los Angeles, California.</p>
      <p>58 Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, Indiana.</p>
      <p>59 Department of Neurology, Emory University, Atlanta, Georgia.</p>
      <p>60 Division of Genetics, Department of Medicine andÂ Partners Center for Personalized Genetic Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.</p>
      <p>61 Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts.</p>
      <p>62 Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.</p>
      <p>63 Department of Pathology (Neuropathology), University of Pittsburgh, Pittsburgh, Pennsylvania.</p>
      <p>64 Institute of Neurology, University College London, Queen Square, London.</p>
      <p>65 Sanders-Brown Center on Aging, Department of Molecular and Biomedical Pharmacology, University of Kentucky, Lexington, Kentucky.</p>
      <p>66 Taub Institute on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University, New York.</p>
      <p>67 Department of Pathology, Duke University, Durham, North Carolina.</p>
      <p>68 Department of Genome Sciences, University of Washington, Seattle, Washington.</p>
      <p>69 Department of Medicine (Medical Genetics), University of Washington, Seattle, Washington.</p>
      <p>70 Sanders-Brown Center on Aging, Department Neurology, University of Kentucky, Lexington, Kentucky.</p>
      <p>71 Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, California.</p>
      <p>72 University of Pittsburgh Alheimer's Disease Research Center, Pittsburgh, Pennsylvania.</p>
      <p>73 Department of Biology, Brigham Young University, Provo, Utah.</p>
      <p>74 Department of Neurology, Oregon Health &amp; Science University, Portland, Oregon.</p>
      <p>75 Department of Neurology, Portland Veterans Affairs Medical Center, Portland, Oregon.</p>
      <p>76 Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California.</p>
      <p>77 Department of Neurology, Boston University, Boston, Massachusetts.</p>
      <p>78 Department of Pathology, Boston University, Boston, Massachusetts.</p>
      <p>79 Department of Neuropsychology, University of California San Francisco, San Fransisco, California.</p>
      <p>80 Department of Molecular &amp; Medical Genetics, Oregon Health &amp; Science University, Portland, Oregon.</p>
      <p>81 Department of Epidemiology, University of Washington, Seattle, Washington.</p>
      <p>82 Department of Neurobiology and Behavior, University of California Irvine, Irvine, California.</p>
      <p>83 Group Health Research Institute, Group Health, Seattle, Washington.</p>
      <p>84 Department of Pathology, University of Washington, Seattle, Washington.</p>
      <p>85 Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington.</p>
      <p>86 Department of Pathology, University of Michigan, Ann Arbor, Michigan.</p>
      <p>87 Department of Biostatistics, Boston University, Boston, Massachusetts.</p>
      <p>88 Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland.</p>
      <p>89 Department of Preventive Medicine, University of Southern California, Los Angeles, California.</p>
      <p>90 Department of Medicine - Pulmonary, New York University, New York.</p>
      <p>91 Department of Neurology, University of Miami, Miami, Florida.</p>
      <p>92 Department of Pathology, University of California San Diego, La Jolla, California.</p>
      <p>93 School of Nursing Northwest Research Group on Aging, University of Washington, Seattle, Washington.</p>
      <p>94 Cognitive Neurology and Alzheimer's Disease Center, Northwestern University, Chicago, Illinois.</p>
      <p>95 Department of Pathology, University of Southern California, Los Angeles, California.</p>
      <p>96 Department of Neurology, Washington University, St. Louis, Missouri.</p>
      <p>97 Department of Biostatistics, Mayo Clinic, Rochester, Minnesota.</p>
      <p>98 Department of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota.</p>
      <p>99 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.</p>
      <p>100 Arizona Alzheimerâs Consortium, Phoenix, Arizona.</p>
      <p>101 Banner Alzheimer's Institute, Phoenix, Arizona.</p>
      <p>102 Department of Psychiatry, University of Arizona, Phoenix, Arizona.</p>
      <p>103 Alzheimer's Disease Center, New York University, New York.</p>
      <p>104 Gertrude H. Sergievsky Center, Columbia University, New York.</p>
      <p>105 Department of Neurology, Columbia University, New York.</p>
      <p>106 Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, Ontario.</p>
      <p>107 Department of Neurology, University of Texas Southwestern, Dallas, Texas.</p>
      <p>108 Department of Radiology and Imaging Sciences, Indiana University, Indianapolis, Indiana.</p>
      <p>109 Department of Pathology (Neuropathology), Rush University Medical Center, Chicago, Illinois.</p>
      <p>110 Department of Psychiatry, University of Southern California, Los Angeles, California.</p>
      <p>111 Department of Pathology, Johns Hopkins University, Baltimore, Maryland.</p>
      <p>112 Sanders-Brown Center on Aging, Department of Anatomy and Neurobiology, University of Kentucky, Lexington, Kentucky.</p>
      <p>113 Department of Pathology &amp; Laboratory Medicine, University of California Los Angeles, Los Angeles, California.</p>
      <p>114 Taub Institute on Alzheimer's Disease and the Aging Brain, Department of Pathology, Columbia University, New York.</p>
      <p>115 Department of Psychiatry &amp; Behavioral Sciences, Duke University, Durham, North Carolina.</p>
      <p>116 Department of Pathology, Oregon Health &amp; Science University, Portland, Oregon.</p>
      <p>117 Evelyn F. McKnight Brain Institute, Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pone.0058618-ErtekinTaner1">
        <label>1</label>
        <mixed-citation publication-type="journal">
<name><surname>Ertekin-Taner</surname><given-names>N</given-names></name> (<year>2010</year>) <article-title>Genetics of Alzheimer disease in the pre- and post-GWAS era</article-title>. <source>Alzheimerâs Res Ther</source>
<volume>2</volume>: <fpage>3</fpage>.<pub-id pub-id-type="pmid">20236449</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Pottier1">
        <label>2</label>
        <mixed-citation publication-type="journal">
<name><surname>Pottier</surname><given-names>C</given-names></name>, <name><surname>Hannequin</surname><given-names>D</given-names></name>, <name><surname>Coutant</surname><given-names>S</given-names></name>, <name><surname>Rovelet-Lecrux</surname><given-names>A</given-names></name>, <name><surname>Wallon</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease</article-title>. <source>Mol Psychiatry</source>
<volume>17</volume>: <fpage>875</fpage>â<lpage>879</lpage>.<pub-id pub-id-type="pmid">22472873</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Farrer1">
        <label>3</label>
        <mixed-citation publication-type="journal">
<name><surname>Farrer</surname><given-names>LA</given-names></name>, <name><surname>Cupples</surname><given-names>LA</given-names></name>, <name><surname>Haines</surname><given-names>JL</given-names></name>, <name><surname>Hyman</surname><given-names>BT</given-names></name>, <name><surname>Kukull</surname><given-names>WA</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>Effects of age, gender and ethnicity on the association of apolipoprotein E genotype and Alzheimer disease</article-title>. <source>JAMA</source>
<volume>278</volume>: <fpage>1349</fpage>â<lpage>1356</lpage>.<pub-id pub-id-type="pmid">9343467</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Hollingworth1">
        <label>4</label>
        <mixed-citation publication-type="journal">
<name><surname>Hollingworth</surname><given-names>P</given-names></name>, <name><surname>Harold</surname><given-names>D</given-names></name>, <name><surname>Sims</surname><given-names>R</given-names></name>, <name><surname>Gerrish</surname><given-names>A</given-names></name>, <name><surname>Lambert</surname><given-names>JC</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease</article-title>. <source>Nat Genet</source>
<volume>43</volume>: <fpage>429</fpage>â<lpage>435</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058618-Naj1">
        <label>5</label>
        <mixed-citation publication-type="journal">
<name><surname>Naj</surname><given-names>AC</given-names></name>, <name><surname>Jun</surname><given-names>G</given-names></name>, <name><surname>Beecham</surname><given-names>GW</given-names></name>, <name><surname>Wang</surname><given-names>L-S</given-names></name>, <name><surname>Vardarajan</surname><given-names>BN</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease</article-title>. <source>Nat Genet</source>
<volume>43</volume>: <fpage>436</fpage>â<lpage>441</lpage>.<pub-id pub-id-type="pmid">21460841</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Kuwano1">
        <label>6</label>
        <mixed-citation publication-type="journal">
<name><surname>Kuwano</surname><given-names>R</given-names></name>, <name><surname>Kuwano</surname><given-names>R</given-names></name>, <name><surname>Miyashita</surname><given-names>A</given-names></name>, <name><surname>Arai</surname><given-names>H</given-names></name>, <name><surname>Asada</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease</article-title>. <source>Hum Mol Genet</source>
<volume>15</volume>: <fpage>2170</fpage>â<lpage>2182</lpage>.<pub-id pub-id-type="pmid">16740596</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Miyashita1">
        <label>7</label>
        <mixed-citation publication-type="journal">
<name><surname>Miyashita</surname><given-names>A</given-names></name>, <name><surname>Arai</surname><given-names>H</given-names></name>, <name><surname>Asada</surname><given-names>T</given-names></name>, <name><surname>Imagawa</surname><given-names>M</given-names></name>, <name><surname>Matsubara</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Genetic association of CTNNA3 with late-onset Alzheimer's disease in females</article-title>. <source>Hum Mol Genet</source>
<volume>16</volume>: <fpage>2854</fpage>â<lpage>2869</lpage>.<pub-id pub-id-type="pmid">17761686</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-McKhann1">
        <label>8</label>
        <mixed-citation publication-type="journal">
<name><surname>McKhann</surname><given-names>G</given-names></name>, <name><surname>Drachman</surname><given-names>D</given-names></name>, <name><surname>Folstein</surname><given-names>M</given-names></name>, <name><surname>Katzman</surname><given-names>R</given-names></name>, <name><surname>Price</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>1984</year>) <article-title>Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease</article-title>. <source>Neurology</source>
<volume>34</volume>: <fpage>939</fpage>â<lpage>944</lpage>.<pub-id pub-id-type="pmid">6610841</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Folstein1">
        <label>9</label>
        <mixed-citation publication-type="journal">
<name><surname>Folstein</surname><given-names>MF</given-names></name>, <name><surname>Folstein</surname><given-names>SE</given-names></name>, <name><surname>McHugh</surname><given-names>PR</given-names></name> (<year>1975</year>) <article-title>âMini-mental stateâ</article-title>. A practical method for grading the cognitive state of patients for the clinician. <source>J Psychiatr Res</source>
<volume>12</volume>: <fpage>189</fpage>â<lpage>198</lpage>.<pub-id pub-id-type="pmid">1202204</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Morris1">
        <label>10</label>
        <mixed-citation publication-type="journal">
<name><surname>Morris</surname><given-names>JC</given-names></name> (<year>1993</year>) <article-title>The Clinical Dementia Rating (CDR): current version and scoring rules</article-title>. <source>Neurology</source>
<volume>43</volume>: <fpage>2412</fpage>â<lpage>2414</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058618-Reisberg1">
        <label>11</label>
        <mixed-citation publication-type="journal">
<name><surname>Reisberg</surname><given-names>B</given-names></name> (<year>1988</year>) <article-title>Functional assessment staging (FAST)</article-title>. <source>Psychopharmacol Bull</source>
<volume>24</volume>: <fpage>653</fpage>â<lpage>659</lpage>.<pub-id pub-id-type="pmid">3249767</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Seo1">
        <label>12</label>
        <mixed-citation publication-type="journal">
<name><surname>Seo</surname><given-names>SW</given-names></name>, <name><surname>Im</surname><given-names>K</given-names></name>, <name><surname>Lee</surname><given-names>JM</given-names></name>, <name><surname>Kim</surname><given-names>YH</given-names></name>, <name><surname>Kim</surname><given-names>ST</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Cortical thickness in single- versus multiple-domain amnestic mild cognitive impairment</article-title>. <source>Neuroimage</source>
<volume>36</volume>: <fpage>289</fpage>â<lpage>297</lpage>.<pub-id pub-id-type="pmid">17459730</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Jun1">
        <label>13</label>
        <mixed-citation publication-type="journal">
<name><surname>Jun</surname><given-names>G</given-names></name>, <name><surname>Vardarajan</surname><given-names>BN</given-names></name>, <name><surname>Buros</surname><given-names>J</given-names></name>, <name><surname>Yu</surname><given-names>C-E</given-names></name>, <name><surname>Hawk</surname><given-names>MV</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>A comprehensive search for Alzheimer disease susceptibility loci in the APOE region</article-title>. <source>Arch Neurol</source>
<volume>69</volume>: <fpage>1270</fpage>â<lpage>1279</lpage>.<pub-id pub-id-type="pmid">22869155</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Purcell1">
        <label>14</label>
        <mixed-citation publication-type="journal">
<name><surname>Purcell</surname><given-names>S</given-names></name>, <name><surname>Neale</surname><given-names>B</given-names></name>, <name><surname>Todd-Brown</surname><given-names>K</given-names></name>, <name><surname>Thomas</surname><given-names>L</given-names></name>, <name><surname>Ferreira</surname><given-names>MA</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>. <source>Am J Hum Genet</source>
<volume>81</volume>: <fpage>559</fpage>â<lpage>575</lpage>.<pub-id pub-id-type="pmid">17701901</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Price1">
        <label>15</label>
        <mixed-citation publication-type="journal">
<name><surname>Price</surname><given-names>AL</given-names></name>, <name><surname>Patterson</surname><given-names>NJ</given-names></name>, <name><surname>Plenge</surname><given-names>RM</given-names></name>, <name><surname>Weinblatt</surname><given-names>ME</given-names></name>, <name><surname>Shadick</surname><given-names>NA</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Principal components analysis corrects for stratification in genome-wide association studies</article-title>. <source>Nat Genet</source>
<volume>38</volume>: <fpage>904</fpage>â<lpage>909</lpage>.<pub-id pub-id-type="pmid">16862161</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Li1">
        <label>16</label>
        <mixed-citation publication-type="journal">
<name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Boehnke</surname><given-names>M</given-names></name>, <name><surname>Abecasis</surname><given-names>GR</given-names></name> (<year>2006</year>) <article-title>Efficient study designs for test of genetic association using sibship data and unrelated cases and controls</article-title>. <source>Am J Hum Genet</source>
<volume>78</volume>: <fpage>778</fpage>â<lpage>792</lpage>.<pub-id pub-id-type="pmid">16642434</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Donnelly1">
        <label>17</label>
        <mixed-citation publication-type="journal">
<name><surname>Donnelly</surname><given-names>P</given-names></name>, <name><surname>Marchini</surname><given-names>J</given-names></name> (<year>2009</year>) <article-title>A flexible and accurate genotype imputation method for the next generation of genome-wide association studies</article-title>. <source>PLoS Genetics</source>
<volume>5</volume>: <fpage>e100529</fpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058618-Willer1">
        <label>18</label>
        <mixed-citation publication-type="journal">
<name><surname>Willer</surname><given-names>CJ</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Abecasis</surname><given-names>GR</given-names></name> (<year>2010</year>) <article-title>METAL: fast and efficient meta-analysis of genomewide association scans</article-title>. <source>Bioinformatics</source>
<volume>26</volume>: <fpage>2190</fpage>â<lpage>2191</lpage>.<pub-id pub-id-type="pmid">20616382</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Rogaeva1">
        <label>19</label>
        <mixed-citation publication-type="journal">
<name><surname>Rogaeva</surname><given-names>E</given-names></name>, <name><surname>Meng</surname><given-names>Y</given-names></name>, <name><surname>Lee</surname><given-names>JH</given-names></name>, <name><surname>Gu</surname><given-names>Y-J</given-names></name>, <name><surname>Zou</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>The sortilin-related receptor SORL1 is functionally and genetically associated with Alzheimer's disease</article-title>. <source>Nat Genet</source>
<volume>39</volume>: <fpage>168</fpage>â<lpage>177</lpage>.<pub-id pub-id-type="pmid">17220890</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Reitz1">
        <label>20</label>
        <mixed-citation publication-type="journal">
<name><surname>Reitz</surname><given-names>C</given-names></name>, <name><surname>Rogaeva</surname><given-names>E</given-names></name>, <name><surname>Lee</surname><given-names>JH</given-names></name>, <name><surname>Tokuhiro</surname><given-names>S</given-names></name>, <name><surname>Bettens</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Association of SORL1 gene variants with Alzheimer's disease: A meta-analysis</article-title>. <source>Arch Neurol</source>
<volume>68</volume>: <fpage>99</fpage>â<lpage>106</lpage>.<pub-id pub-id-type="pmid">21220680</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Cuenco1">
        <label>21</label>
        <mixed-citation publication-type="journal">
<name><surname>Cuenco</surname><given-names>KT</given-names></name>, <name><surname>Lunetta</surname><given-names>K</given-names></name>, <name><surname>Baldwin</surname><given-names>CT</given-names></name>, <name><surname>McKee</surname><given-names>AC</given-names></name>, <name><surname>Guo</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Distinct variants in SORL1 are associated with cerebrovascular and neurodegenerative changes related to Alzheimer disease</article-title>. <source>Arch Neurol</source>
<volume>65</volume>: <fpage>1640</fpage>â<lpage>1648</lpage>.<pub-id pub-id-type="pmid">19064752</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Gordon1">
        <label>22</label>
        <mixed-citation publication-type="journal">
<name><surname>Gordon</surname><given-names>D</given-names></name>, <name><surname>Haynes</surname><given-names>C</given-names></name>, <name><surname>Blumenfeld</surname><given-names>J</given-names></name>, <name><surname>Finch</surname><given-names>SJ</given-names></name> (<year>2005</year>) <article-title>PAWE-3D: visualizing power for association with error in case-control genetic studies of complex traits</article-title>. <source>Bioinformatics</source>
<volume>21</volume>: <fpage>3935</fpage>â<lpage>3937</lpage>.<pub-id pub-id-type="pmid">16123114</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Li2">
        <label>23</label>
        <mixed-citation publication-type="journal">
<name><surname>Li</surname><given-names>HL</given-names></name>, <name><surname>Shi</surname><given-names>SS</given-names></name>, <name><surname>Guo</surname><given-names>QH</given-names></name>, <name><surname>Ni</surname><given-names>W</given-names></name>, <name><surname>Dong</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>PICALM and CR1 variants are not associated with sporadic Alzheimer's disease in Chinese patients</article-title>. <source>J Alzheimers Dis</source>
<volume>25</volume>: <fpage>111</fpage>â<lpage>117</lpage>.<pub-id pub-id-type="pmid">21358043</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Yu1">
        <label>24</label>
        <mixed-citation publication-type="journal">
<name><surname>Yu</surname><given-names>JT</given-names></name>, <name><surname>Song</surname><given-names>JH</given-names></name>, <name><surname>Ma</surname><given-names>T</given-names></name>, <name><surname>Zhang</surname><given-names>W</given-names></name>, <name><surname>Yu</surname><given-names>NN</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Genetic association of PICALM polymorphisms with Alzheimer's disease in Han Chinese</article-title>. <source>J Neurol Sci</source>
<volume>300</volume>: <fpage>78</fpage>â<lpage>80</lpage>.<pub-id pub-id-type="pmid">20951388</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Chen1">
        <label>25</label>
        <mixed-citation publication-type="journal">
<name><surname>Chen</surname><given-names>LH</given-names></name>, <name><surname>Kao</surname><given-names>PY</given-names></name>, <name><surname>Fan</surname><given-names>YH</given-names></name>, <name><surname>Ho</surname><given-names>DT</given-names></name>, <name><surname>Chan</surname><given-names>CS</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population</article-title>. <source>Neurobiol Aging</source>
<volume>33</volume>: <fpage>210.e1</fpage>â<lpage>7</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058618-Takei1">
        <label>26</label>
        <mixed-citation publication-type="journal">
<name><surname>Takei</surname><given-names>N</given-names></name>, <name><surname>Miyashita</surname><given-names>A</given-names></name>, <name><surname>Tsukie</surname><given-names>T</given-names></name>, <name><surname>Arai</surname><given-names>H</given-names></name>, <name><surname>Asada</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese</article-title>. <source>Genomics</source>
<volume>93</volume>: <fpage>441</fpage>â<lpage>448</lpage>.<pub-id pub-id-type="pmid">19442637</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Andersen1">
        <label>27</label>
        <mixed-citation publication-type="journal">
<name><surname>Andersen</surname><given-names>OM</given-names></name>, <name><surname>Reiche</surname><given-names>J</given-names></name>, <name><surname>Schmidt</surname><given-names>V</given-names></name>, <name><surname>Gotthardt</surname><given-names>M</given-names></name>, <name><surname>Spoelgen</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>102</volume>: <fpage>13461</fpage>â<lpage>13466</lpage>.<pub-id pub-id-type="pmid">16174740</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Fjorback1">
        <label>28</label>
        <mixed-citation publication-type="journal">
<name><surname>Fjorback</surname><given-names>AW</given-names></name>, <name><surname>Seaman</surname><given-names>M</given-names></name>, <name><surname>Gustafsen</surname><given-names>C</given-names></name>, <name><surname>Mehmedbasic</surname><given-names>A</given-names></name>, <name><surname>Gokool</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing</article-title>. <source>J Neurosci</source>
<volume>32</volume>: <fpage>1467</fpage>â<lpage>1480</lpage>.<pub-id pub-id-type="pmid">22279231</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Dodson1">
        <label>29</label>
        <mixed-citation publication-type="journal">
<name><surname>Dodson</surname><given-names>SE</given-names></name>, <name><surname>Andersen</surname><given-names>OM</given-names></name>, <name><surname>Karmali</surname><given-names>V</given-names></name>, <name><surname>Fritz</surname><given-names>JJ</given-names></name>, <name><surname>Cheng</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease</article-title>. <source>J Neurosci</source>
<volume>28</volume>: <fpage>12877</fpage>â<lpage>12886</lpage>.<pub-id pub-id-type="pmid">19036982</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Klsch1">
        <label>30</label>
        <mixed-citation publication-type="journal">
<name><surname>KÃ¶lsch</surname><given-names>H</given-names></name>, <name><surname>Jessen</surname><given-names>F</given-names></name>, <name><surname>Wiltfang</surname><given-names>J</given-names></name>, <name><surname>Lewczuk</surname><given-names>P</given-names></name>, <name><surname>Dichgans</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease</article-title>. <source>Neurosci Lett</source>
<volume>440</volume>: <fpage>68</fpage>â<lpage>71</lpage>.<pub-id pub-id-type="pmid">18541377</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0058618-Vardarajan1">
        <label>31</label>
        <mixed-citation publication-type="journal">
<name><surname>Vardarajan</surname><given-names>BN</given-names></name>, <name><surname>Breusegem</surname><given-names>SY</given-names></name>, <name><surname>Harbour</surname><given-names>ME</given-names></name>, <name><surname>Rivka</surname><given-names>Inzelberg</given-names></name>, <name><surname>Friedland</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Identification of Alzheimer disease associated variants in genes that regulate retromer function</article-title>. <source>Neurobiol Aging</source>
<volume>33</volume>: <fpage>2231.e15</fpage>â<lpage>2231.e30</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058618-Choy1">
        <label>32</label>
        <mixed-citation publication-type="journal">
<name><surname>Choy</surname><given-names>RW-Y</given-names></name>, <name><surname>Cheng</surname><given-names>Z</given-names></name>, <name><surname>Schekman</surname><given-names>R</given-names></name> (<year>2012</year>) <article-title>Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid Î² (AÎ²) production in the trans-Golgi network</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>109</volume>: <fpage>2077</fpage>â<lpage>2082</lpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>